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Biofabrication, Biomechanics and Biocompatibility of Nanocellulose-based Scaffolds for 
Auricular Cartilage Regeneration 
HÉCTOR D. MARTÍNEZ ÁVILA 
ABSTRACT 
In about 2:10,000 births the external part of the ear, the auricle, is severely malformed or absent. 
Furthermore, tumors and trauma can cause defects to the auricle.  For patients with dysplasia of the 
auricle, and especially for children, an inconspicuous outer appearance with life-like auricles is 
important for their psychological and emotional well being as well as their psycho-social development. 
Auricular reconstruction remains a great challenge due to the complexity of surgical reconstruction 
using rib cartilage. Despite the advances in stem cell technology and biomaterials, auricular cartilage 
tissue engineering (TE) is still in an early stage of development due to critical requirements demanding 
appropriate mechanical properties and shape stability of the tissue-engineered construct. This thesis has 
focused on developing patient-specific tissue-engineered auricles for one-step surgery using a novel 
biomaterial, bacterial nanocellulose (BNC), seeded with human nasoseptal chondrocytes (hNC) and 
bone marrow mononuclear cells (MNC). 
Biomechanical properties of human auricle cartilage were measured and used as a benchmark for 
tuning BNC properties. In order to meet the biomechanical requirements, a scaffold with bilayer 
architecture composed of a dense BNC support layer and a macroporous structure was designed. 
Firstly, the biocompatibility of the dense BNC layer was investigated, demonstrating a minimal foreign 
body response according to standards set forth in ISO 10993. Secondly, different methods to create 
macroporous BNC scaffolds were studied and the redifferentiation capacity of hNCs was evaluated in 
vitro; revealing that macroporous BNC scaffolds support cell ingrowth, proliferation and neocartilage 
formation. The bilayer BNC scaffold was biofabricated and tested for endotoxins and cytotoxicity 
before evaluating in long-term 3D culture, and subsequently in vivo for eight weeks—in an 
immunocompromised animal model. The results demonstrated that the non-pyrogenic and non-
cytotoxic bilayer BNC scaffold offers a good mechanical stability and maintains a structural integrity, 
while providing a porous 3D environment that is suitable for hNCs and MNCs to produce neocartilage, 
in vitro and in vivo. Furthermore, patient-specific auricular BNC scaffolds with bilayer architecture 
were biofabricated and seeded with autologous rabbit auricular chondrocytes (rAC) for implantation in 
an immunocompetent rabbit model for six weeks. The results demonstrated the shape stability of the 
rAC-seeded scaffolds and neocartilage depositions in the immunocompetent autologous grafts. 3D 
bioprinting was also evaluated for biofabrication of patient-specific, chondrocyte-laden auricular 
constructs using a bioink composed of nanofibrillated cellulose and alginate. Bioprinted auricular 
constructs showed an excellent shape and size stability after in vitro culture. Moreover, this bioink 
supports redifferentiation of hNCs while offering excellent printability, making this a promising 
approach for auricular cartilage TE. Furthermore, the use of bioreactors is essential for the development 
of tissue-engineered cartilage in vitro. Thus, a compression bioreactor was utilized to apply dynamic 
mechanical stimulation to cell-seeded constructs as a means to enhance production of extracellular 
matrix in vitro.  
In this work, a potential clinical therapy for auricular reconstruction using tissue-engineered auricles is 
demonstrated; where BNC is proposed as a promising non-degradable biomaterial with good chemical 
and mechanical stability for auricular cartilage TE. Although the primary focus of this thesis is on 
auricular reconstruction, the methods developed are also applicable in the regeneration of other 
cartilage tissues such as those found in the nose, trachea, spine and articular joints. 
 
Keywords: Tissue Engineering; 3D Bioprinting; Auricular reconstruction; Auricular Cartilage; 
Neocartilage; Bacterial Nanocellulose; Nanofibrillated Cellulose; Nasoseptal Chondrocytes; 
Mononuclear Cells 
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1 
CHAPTER 1 
 
1 INTRODUCTION 
1.1 Motivation 
 
Cartilage is a tissue with a limited capacity for self-repair due to its avascular nature and sparse 
distribution of highly differentiated cells, i.e. the chondrocytes. The cartilage found in the auricle 
(e.g. outer ear), can be malformed by congenital defects or damaged by trauma. Malformations of 
the auricle are collectively termed microtia.1 The reported prevalence of microtia varies among 
regions, from 0.83 to 12.0 per 10,000 births, and the prevalence is considered to be higher in 
Native Americans, Andeans, Hispanics and Asians.2 Although the diagnosis of microtia 
encompasses a spectrum of phenotypes, even minor deformities may bring psychological distress 
upon the affected individuals, due to actual or perceived defect and its effect on psychosocial 
development. For patients with microtia, especially children, an inconspicuous outer appearance 
with life-like auricles is important for their psychological and emotional well-being. Without 
reconstructive surgery many patients suffer from reduced self-confidence, which can lead to 
severe psychosocial problems.3,4 In addition, more than 90% of individuals diagnosed with 
microtia experience hearing loss on the affected side.1,5,6 For these reasons, successful auricle 
restoration is of utmost concern within the field of reconstructive surgery. 
 
Today, auricular reconstruction uses multiple-step surgical techniques where autologous tissue, 
such as rib cartilage, is formed into the shape of the auricle and supported by skin.7 Due to the 
complexity of this multistep procedure, unsatisfactory cosmetic results might occur. Moreover, 
harvesting large pieces of rib cartilage causes donor-site morbidity with a risk for lung collapse or 
thorax deformities, especially in young patients.8 Alternatively, synthetic implants made of 
polyethylene can be implanted with a better cosmetic outcome but higher risk for infection and 
extrusion.9,10 Therefore, there is still a great need for competitive alternatives. 
 
A new technology that is being developed for reconstruction of the auricle is tissue 
engineering.11,12 This technology uses various scaffold materials and structures to support the 
cells harvested from the patient, followed by implantation of the engineered-tissue into the 
damaged area. It is of great importance that the scaffold material used can be shaped into the 
desired form and allows the seeded cells to perform the function as in the native tissue. 
Furthermore, the engineered tissue should have long-term durability in vivo.13,14 The pioneering 
work by Vacanti et al. demonstrated that chondrocytes seeded onto synthetic, biodegradable 
scaffolds with a complex architecture, like a human ear, could produce neocartilage after 
transplantation in athymic mice.15,16 The engineering of autologous tissues and organs is a 
promising alternative therapy with potential for tissue replacement.13,14 
 
Although scientists have been investigating the possibility to engineer cartilage-like structures in 
the shape of a human auricle since the early 1990s,12,15 few successful outcomes have been 
reported.17-19 Most studies that have used biodegradable scaffold materials have resulted in poor 
structural integrity (i.e. shape and size stability) of the auricular scaffold after implantation; 
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caused by the short-lived chemical and mechanical stability.16,20-23 On the other hand, recent 
studies that have investigated the use of non-degradable biomaterials for auricular cartilage 
reconstruction have reported a better structural integrity of the implant;18,19,24 likely caused by the 
chemical stability of the support biomaterial, which translates into long-lasting mechanical 
properties even after implantation. Thus, there is evidence that problems that have arisen in 
auricular cartilage TE, particularly poor structural integrity of the implant, could be solved using 
non-degradable scaffold materials.  
 
Besides maintaining a long-term structural integrity, the engineered auricular graft must have 
adequate mechanical properties and porosity, as these are key factors for successful auricular 
cartilage tissue engineering (TE). The scaffold must be mechanically stable while providing a 
porous architecture that supports cell ingrowth and neocartilage formation. Another important 
requirement for engineered-auricular grafts is to be able to control the external shape of the 
implant to obtain satisfying esthetic results. This outcome is often used as a measure of success 
for a potential biomaterial.18,19,22 However, most efforts in auricular cartilage TE have used 
standardized auricular shapes.18,19,22,24 The optimal esthetic outcome would be to produce 
scaffolds that mimic the shape of patient’s own auricle. That is, the shape must be patient-
specific. A number of technologies can be used to acquire the 3D shape of the intact contralateral 
auricle of a patient undergoing surgical auricular reconstruction. After processing the patient’s 
medical images, a 3D model is available for the production of a patient-specific auricular scaffold 
for TE purposes.25 
 
To engineer the auricle, there is a need for a cell source that can be easily accessible and that has 
the ability to form cartilage of sufficient quality. Potential cell sources include auricular 
chondrocytes,26 nasoseptal chondrocytes27 and mesenchymal stem cells from bone marrow and 
adipose tissue.28,29 The use of autologous cells in cartilage repair is an attractive strategy as it may 
result in regeneration of the lost tissue. However, the clinical application of a cell-aided treatment 
does feature challenges – a limited supply of autologous chondrocytes with the proper phenotype 
being the most stringent one. Autologous cells could be isolated within the operating room and 
applied directly in order to avoid double surgery and cell culture. In addition, the combination of 
chondrocytes with a less limited source of autologous cells, such as bone marrow mononuclear 
cells (MNC), can overcome the challenge of having too few cells and may even increase the 
treatment’s performance.30,31 The use of freshly isolated autologous cells, together with a non-
degradable material, represents a novel strategy for delivering tissue-engineered auricles in a 
straightforward manner to the patients, using an undemanding one-step surgical method. 
Most auricular cartilage TE strategies have revolved around biodegradable scaffolds, where the 
hypothetical optimum has been the scaffold’s degradation orchestrated by the neo-tissue 
formation. It would be ideal if the scaffold could be degraded by the time the neocartilage has 
reached full mechanical strength. However, fine-tuning this intricate play has proven to be a 
challenge in TE. As opposed to the many biodegradable scaffolds previously evaluated for 
auricular cartilage TE, the long-term structural integrity of bacterial nanocellulose (BNC) 
scaffolds should not be compromised after implantation since humans do not produce enzymes 
capable of breaking down cellulose. This would allow the material to retain the shape of the 
auricle after implantation. We aim for a hybrid implant – BNC well integrated with the host and 
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neo-tissue. The non-degradable BNC will provide long-term structural integrity after 
implantation, and has previously shown remarkable integration with the host tissue in different 
animal models.32-34 The overall aim of this thesis is to design and biofabricate non-degradable, 
patient-specific BNC scaffolds for use with cells in auricular cartilage regeneration. 
 
1.2 Hypotheses 
 
• The biomechanical properties of BNC could be increased by densification of the BNC 
network (i.e. increase cellulose content) and potentially match the mechanical properties 
of cartilage tissues.  
 
• Although native BNC (1% cellulose content, 99% water) is known for its 
biocompatibility, there are no studies that have investigated the host tissue response to 
densified BNC hydrogels. We hypothesized that the biocompatibility of BNC should not 
be affected after densification of the nanocellulose network, provided that endotoxin 
levels in the material are below the endotoxin limit set by the FDA for medical devices. 
 
• Porous BNC-Alginate composite scaffolds will support neocartilage formation by human 
chondrocytes, as it has been shown that these biomaterials maintain a chondrogenic 
phenotype. 
 
• The combination of a dense BNC layer with a porous BNC-Alginate layer will result in a 
scaffold architecture with high porosity for cell infiltration and neocartilage formation, 
while providing good structural integrity after implantation. 
 
• The long-term structural integrity of auricular BNC scaffolds seeded with autologous 
chondrocytes should not be compromised after implantation in an immunocompetent 
animal model. 
 
• 3D bioprinted cell-laden nanocellulose-alginate constructs should support neocartilage 
formation by human chondrocytes in chondrogenic differentiation medium conditions. 
 
• Dynamic mechanical stimulation to cell-seeded BNC constructs will have a positive effect 
on the development of the neo-tissue.  
  
 
4 
CHAPTER 2 
 
2 BACKGROUND 
2.1 Clinical needs in auricular cartilage reconstruction 
 
The cartilage found in the auricle, external part of the ear, can be malformed by congenital 
defects or damaged by traumatic injuries, cancer or acute auricular hematoma35 (Figure 1). 
Malformations of the auricle are collectively termed microtia. Thus, the diagnosis of microtia 
encompasses a spectrum of congenital defects that range in severity from mild structural 
abnormalities to complete absence of the ear (anotia).1 
 
 
Figure 1 – Photographs of individuals with different types of microtia. (a) typical ear, (b-d) first degree dysplasia, 
(e) second degree dysplasia, (f-j) third degree dysplasia. Classification proposed by Hunter et al. 36 Reprinted from 
Microtia: Epidemiology and genetics, Daniela V. Luquetti, Carrie L. Heike, Anne V. Hing, Michael L. Cunningham 
and Timothy C. Cox, Am J Med Genet Part A 158A, Copyright © 2011 Wiley Periodicals, Inc., with permission from 
John Wiley and Sons.2 
The reported prevalence of microtia varies among regions, from 0.83 to 12.0 per 10,000 births, 
and the prevalence is considered to be higher in Native Americans, Andeans, Hispanics and 
Asians.2 Population-based studies on microtia prevalence conducted in France (0.83), Sweden 
(2.35), Finland (4.34), and United States (2.0-3.8) found prevalence rates ranging between 0.83 
and 4.34 per 10,000 births. Microtia is more common among males, 20–40% higher compared to 
females, and the right ear is affected in approximately 60% of the cases. Microtia can also occur 
bilaterally in approximately 10–20% of the cases.6,37-40 
 
a b c d e
f g h i j 
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Although the diagnosis of microtia encompasses a spectrum of phenotypes, even minor 
deformities may bring psychological distress upon the affected individuals, due to actual or 
perceived defect and its effect on psychosocial development. For patients with microtia, 
especially children, an inconspicuous outer appearance with life-like auricles is important for 
their psychological and emotional well-being. Without reconstructive surgery many patients 
suffer from reduced self-confidence, which can lead to severe psychosocial problems.3,4,41 In 
addition, more than 90% of individuals diagnosed with microtia experience hearing loss on the 
affected side.1,5,6 For these reasons, successful auricle restoration is of utmost concern within the 
field of reconstructive surgery. 
 
2.2 State-of-the art in auricular cartilage reconstruction 
 
The first auricular reconstruction technique using autologous costal cartilage was developed by 
Tanzer in the late 1950s.42 Today, the most commonly used methods for auricular reconstruction 
are based on the work of Brent43 and Nagata.44 These procedures require multiple surgeries and 
the complexity of the operation depends on the size of the defect. The current gold standard for 
reconstruction of microtia and other auricular deformities uses multiple-step surgical techniques 
where autologous tissue, such as costal cartilage, is formed into the shape of the auricle and 
implanted under the periauricular skin. For total reconstruction, the sixth, seventh, and eighth 
costal ribs are harvested (Figure 2). The sixth and seventh ribs are used to form the auricular 
body framework, whereas the eighth rib is used to form the helical structure.7 Implantation is then 
performed in 4 stages43 or 2 stages.44 In step 1, the autologous framework is implanted 
subcutaneously. In steps 2 and 3, remnants of the auricle are used to complete the implanted 
framework and the tragus is reconstructed. In step 4, the framework is elevated from the head. 
Two-stage implantation techniques combine the first three steps into a single surgery. The main 
advantage of the 2-stage techniques is the reduction of time. However, these techniques also 
require more experienced surgeons since they are more challenging.45 Thus, due to the 
complexity of multiple-step surgical techniques, unsatisfactory cosmetic results might occur. 
Moreover, harvesting large pieces of rib cartilage causes donor-site morbidity with a risk for lung 
collapse or thorax deformities, especially in young patients.8 
 
An alternative approach to reconstruct the auricle has been to use alloplastic implants such as 
silicone46,47 or porous high-density polyethylene.48,49 Advantages of alloplastic implants include 
unlimited availability, consistent predetermined shape and shortened operation time. However, 
the use of alloplastic implants is associated with increased rates of infection, extrusion and 
uncertain long-term durability.9,10 Alloplastic auricular reconstruction using prostheses anchored 
with magnets on osseointegrated implants is considered in patients with poor local tissue 
resulting from radiation, cancer resection, absence of lower half of the auricle and failed 
autogenous reconstruction.7,50,51 
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Figure 2 – For total auricular reconstruction, (a) the sixth, seventh, and eighth costal ribs are first harvested. (b) 
The sixth and seventh ribs are used to form the auricular body framework, whereas the eighth rib is used to form the 
helical structure. Reprinted from J Plast Reconstr Aesthet Surg, 61, B. Pan, H. Jiang, D. Guo, C. Huang, S. Hu, H. 
Zhuang, Microtia: ear reconstruction using tissue expander and autogenous costal cartilage, Pages S98–S103, 
Copyright © 2008, with permission from Elsevier.52 
 
A new technology that is being developed for reconstruction of the auricle is tissue 
engineering.11,12 This technique uses various scaffold materials to support the cells harvested 
from the patient, followed by implantation of the engineered-tissue into the damaged area. It is of 
great importance that the scaffold material used can be shaped into the desired form and allows 
the seeded cells to perform the function as in the native tissue. Furthermore, the engineered-tissue 
should have long-term durability in vivo. The pioneering work by Vacanti et al. demonstrated that 
chondrocytes seeded onto synthetic, biodegradable scaffold with a complex architecture like a 
human ear could produce neocartilage after transplantation in athymic mice.15,16 The engineering 
of autologous tissues and organs is a promising alternative therapy with potential for tissue 
replacement. This thesis contributes to the field of auricular cartilage tissue engineering. 
 
2.3 The ear 
 
The outer ear is responsible for receiving sound waves and transmitting those inwards. It is 
further divided into the auricle, the external auditory canal and the eardrum. The auricle is the 
visible part of the outer ear and consists of elastic cartilage, which is covered by skin.53 Auricular 
cartilage is the main component of the external ear. It is surrounded by a thin layer of 
perichondrium, a connective tissue that connects it to the highly vascularized skin and provides 
the necessary nutrients.7 The first elevations that will later build the auricle, arise already at the 
sixth week of embryonic development.54 
 
2.3.1 Auricular cartilage and the extracellular matrix 
Several types of cartilage are found in the body: fibrous, hyaline and elastic cartilage. 
Fibrocartilage is found in the menisci and intervertebral discs of the spine, hyaline cartilage can 
be found in the joints and elastic cartilage in the external ear.53,55 Cartilage consists of 
chondrocytes, extracellular matrix (ECM) and water. It is the composition of the ECM that 
determines the type of cartilage, where variation in composition among different types of 
b a 
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cartilage is due to site-specific mechanical loading.56,57 Cartilage has been suggested to have a 
hydrogel-like structure58 as it is composed of a large amount of water (60-80%). Cartilage has a 
sparse distribution of highly differentiated cells, i.e. the chondrocytes, which are found in small 
empty spaces called lacunae and are surrounded by ECM.59 Furthermore, cartilage is an avascular 
tissue with no nerve supply, which means that nutrients and waste can only be exchanged by 
diffusion and the self-repair capacity of the tissue is limited. This limited capacity is further 
reduced due to the low amount of chondrocytes in the tissue and limited supply of progenitor 
cells. 57,59  
 
The ECM functions as a physical support for cells, but it also contains ligands for cell adhesion 
and migration, and provides biological factors to control cell function. It is produced and 
maintained by the local cells, where the matrix composition determines its biomechanical 
function. The ECM of elastic cartilage consists of fibrous proteins (elastin and type II and V 
collagen) and proteoglycans (aggrecan), where the most abundant matrix protein is type II 
collagen.56,60 Among the cartilage subtypes, elastin is almost exclusively found in elastic 
cartilage.56,61 The fibrous proteins in the ECM are responsible for the tissue’s tensile strength, 
high resilience and large extensibility.56 A proteoglycan typical for cartilage is aggrecan, which 
consists of glycosaminoglycans (GAG),62,63 such as chondroitin sulfate and keratin sulfate, 
attached to a core protein. Chondroitin sulfate is an important structural component of cartilage 
and provides much of its resistance to compression, which is due to the binding of water to 
GAGs. Hyaluronan is also an important component of cartilage. When aggrecan monomers bind 
to hyaluronan in the presence of link protein, large and highly negative-charged proteoglycan 
aggregates form. These aggregates bind water, growth factors and cytokines.62,63 Due to the 
limited self-renewal and self-repair capacity of cartilage, tissue engineering can provide 
unlimited possibilities in auricular reconstruction.11,12,64 
 
2.4 Auricular cartilage tissue engineering 
 
Since the early 1990s scientists have investigated the possibility to engineer cartilage-like 
structures in the shape of a human auricle.15 In tissue engineering (TE) applications, scaffolds are 
used to create a mechanical and biochemical environment that is adequate for development of the 
tissue of interest. That is, the scaffold should promote cell adhesion, proliferation and 
differentiation. Additionally, the shape of the scaffolds should be retained until the neo-tissue 
matures and is able to maintain the shape of the construct, in this case an auricle shape. 
 
2.4.1 Scaffold materials and outcomes 
Most scaffold materials evaluated for auricular cartilage TE have been synthetic biodegradable 
polymers: polylactic acid (PLA),16,22,65 polyglycolic acid (PGA),16,22,65-67 polycaprolactone 
(PCL),22 poly-4-hydroxybutyrate (P4HB),22 and their copolymers.20,21,23,68,69 The combination of 
these different polymers allows tuning of the mechanical properties as well as the degradation 
rate of the scaffold. The longest in vivo studies reported were performed over a period of 10 and 3 
months in immunocompromised21-23 and immunocompetent22 animal models, respectively. All 
studies performed in immunocompromised mouse models reported cartilage formation and 
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adequate shape stability at 10 months post-implantation, based on a qualitative assessment of 
shape and size of the implant. However, in the immunocompetent rabbit model, Shieh et al. 
reported a severe foreign body reaction in all investigated polymeric scaffolds (PGA coated with 
PLA, PCL and P4HB) and a severe deformation and collapse of the implants at 3 months post-
implantation (no images were shown). The foreign body reaction was attributed to the 
degradation products of the scaffolds, whereas the loss of shape stability was presumably caused 
by the inflammatory reaction and skin contraction force against the implants.22 
 
2.4.2 Requirements for tissue-engineered auricles 
Although several groups have attempted to engineer auricular cartilage,11,12 few successful 
outcomes have been reported.17-19 Most studies that have used biodegradable scaffold materials 
have resulted in poor structural integrity (i.e. shape and size stability) of the auricular scaffold 
after implantation; caused by the short-lived chemical and mechanical stability.16,20-23 On the 
other hand, recent studies that have investigated the use of non-degradable biomaterials for 
auricular cartilage reconstruction have reported a better structural integrity of the implant;18,19,24 
likely caused by the chemical stability of the support biomaterial, which translates into long-
lasting mechanical properties even after implantation. Thus, there is evidence that common 
problems in auricular cartilage TE, particularly poor structural integrity of the implant, could be 
solved using a non-degradable scaffold material. As opposed to the many biodegradable scaffolds 
previously evaluated for auricular cartilage TE, the long-term structural integrity of bacterial 
nanocellulose (BNC) scaffolds should not be compromised after implantation since humans do 
not produce enzymes capable of breaking down cellulose.70 This would allow the material to 
retain the shape of the auricle after implantation. Besides maintaining a long-term structural 
integrity, the engineered auricular graft must have adequate mechanical properties and porosity, 
as these are key factors for successful auricular cartilage TE. The scaffold must be mechanically 
stable while providing a porous architecture that supports cell ingrowth and neocartilage 
formation. 
 
It is key in the field of auricular reconstructive surgery to control the external shape of the 
implant to obtain satisfying esthetic results. This outcome is often used as a measure of success 
for a potential biomaterial.18,19,22 However, most efforts in auricular cartilage TE have used 
standardized auricular shapes.18,19,22,24 The optimal esthetic outcome would be to produce 
scaffolds that mimic the shape of patient’s own auricle. That is, the shape must be patient-
specific. Furthermore, the scaffold should mimic the shape of the auricular cartilage, rather than 
the external ear. Consequently, in this thesis we aimed at producing patient-specific BNC 
scaffolds with the shape of auricular cartilage. A number of technologies can be used to acquire 
the 3D shape of the intact contralateral auricle of a patient undergoing surgical auricular 
reconstruction. Protocols that can be applied in daily clinical practice with existing infrastructure 
have also been developed. These methods offer high precision and accuracy to detect patient-
specific variation in auricular cartilage geometry. After processing the patient’s medical images a 
3D model is available for the production of a patient-specific auricular scaffold for TE 
purposes.25 
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To engineer the auricle, there is a need for a cell source that can be easily accessible and that 
has the ability to form cartilage of sufficient quality. Cells from auricular cartilage would be 
optimal since they have already been shown to produce elastic cartilage in a tissue engineering 
setting.26 However, if the patient has no or very small auricles, a different source is needed. Nasal 
septal cartilage is an option,27 although less optimal because it tends to form hyaline cartilage 
rather than elastic cartilage. Moreover, harvesting nasal cartilage will create a defect in the nasal 
septum that, albeit small, cannot be regenerated. Mesenchymal stem cells are available in bone 
marrow and adipose tissue and can be harvested easily in surgery in large quantities. Cells from 
these sources are known to have the capacity to differentiate into chondrocytes,28,29 although 
formation of stable, more specific elastic cartilage remains to be shown. The use of autologous 
cells in cartilage repair is an attractive strategy as it may result in regeneration of the lost tissue. 
However, the clinical application of a cell-aided treatment does feature challenges – a limited 
supply of autologous chondrocytes with the proper phenotype being the most stringent one. To 
cancel out cell culture, including the concomitant laboratory logistics and the double surgery, 
autologous cells should be isolated within the operating room and applied directly. In addition, 
the combination of chondrocytes with a less limited source of autologous cells, such as bone 
marrow mononuclear cells, can overcome the challenge of having too few cells and may even 
increase the treatment’s performance.30,31 The use of freshly isolated autologous cells, together 
with a non-degradable material, represents a novel strategy for delivering tissue-engineered 
auricles in a straightforward manner to the patients, using an undemanding one-step surgical 
method. 
 
2.5 Bacterial nanocellulose as a biomaterial 
 
Cellulose is a polysaccharide consisting of chains of (1–4)-linked glucose monomers and is the 
most abundant polymer in nature. Although it is generally considered a plant material, some 
bacteria also produce cellulose. In nature, cellulose-producing bacteria are found in rotten fruits 
and vegetables. Bacterial nanocellulose (BNC) is the extracellular product of Gluconacetobacter 
xylinus. These gram-negative aerobic bacteria produce pure nanocellulose fibrils in the presence 
of sugar and oxygen,71 where the production of cellulose occurs mainly at the air-liquid interface. 
BNC can hold as much as 100 times its dry weight of water.72 Its high water content suggests that 
it can be seen as a hydrogel, although not by definition, as it is not a network of polymer chains 
that are water-soluble. Hydrogels are known for their favorable biocompatible properties due to 
little protein adsorption. BNC holds interesting properties for tissue engineering applications, as 
it is a biomaterial with excellent biocompatibility and remarkable tissue integration 
capability.32,34,73,74 
 
The past decade has seen a tremendous interest of scientists evaluating BNC for several tissue 
engineering applications with positive outcomes reported.34,75-82 The material-cell interaction and 
subsequent positive effects on cell fate processes could be attributed to the highly hydrated 
nanocellulose fibrils and their morphological similarity with extracellular matrix components 
such as collagen.76 Several in vitro studies of BNC scaffolds seeded with bovine articular 
chondrocytes and human articular, auricular and nasoseptal chondrocytes have also exhibited 
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good cell adhesion, proliferation and, most importantly, have demonstrated the maintenance of 
chondrogenic phenotype—as confirmed by the synthesis of cartilage-specific ECM.75,78,81,83 
 
2.5.1 Biomedical applications of bacterial nanocellulose  
BNC products, such as temporary skin, have been introduced into the wound care market. BNC 
films have found an application in the health care sector because of their unique absorption 
properties. Cellulose has been most commonly used in applications such as blood purification, 
anticoagulant and plasma expander in aqueous systems. More recently, medical devices made 
from BNC are used in the clinic as wound and burn dressings (e.g. Dermafill®, Bioprocess®, 
XCell® and Biofill®), surgical meshes (e.g. Xylos®, Macro-Porous Surgical Mesh and 
Securian®) and dura mater substitutes (SyntheCel® Dura Repair), which have been used 
successfully to repair dural defects in 62 patients.84 
 
2.5.2 Biofabrication of macroporous bacterial nanocellulose scaffolds 
BNC is a novel biomaterial with potential use in several TE applications. However, its dense 
nanocellulose network prevents cells from penetrating the material. To circumvent this problem, 
several techniques have been developed to create pores and support cell ingrowth in BNC 
scaffolds by tuning pore size and pore interconnectivity during biosynthesis of BNC,76 via laser 
ablation75 and freeze-dry processing.85 Such macroporous BNC scaffolds have been shown to 
provide an adequate environment that supports ingrowth and differentiation of bovine and human 
chondrocytes.75,78,81,83 
 
2.5.3  Purification of bacterial nanocellulose 
The purification of BNC consists on removing all bacterial residues, chiefly lipopolysaccharides 
(LPS), from the BNC network; which results in a material that is composed of pure cellulose and 
water. LPS, also known as endotoxins, are found in the outer membrane of gram-negative 
bacteria. These molecules consist of an O-antigen glycan, a core oligosaccharide, and a lipid A—
known as a toxic fatty acid.86 LPS are considered to be the most potent microbial pyrogens 
responsible for triggering the immune system.87 When endotoxins enter the blood stream, they 
bind to circulating LPS-binding proteins and subsequently to the Toll-like receptor 4 on many 
leukocytes, primarily macrophages and B cells. This binding initiates the secretion of pro-
inflammatory cytokines to counterattack the microbial invasion. High levels of LPS in the 
bloodstream trigger the production of excessive amounts of cytokines (IL-1ß, IL-1α, IL-6, IL-8, 
and TNF), causing severe infection and inflammation that can lead to fatal septic shock.88,89 Due 
to the high risks associated with endotoxin contamination in medical devices, the United States 
Food and Drug Administration (FDA) has set guidelines for endotoxin limits in medical devices, 
which are no more than 0.5 endotoxin units (EU)/ml or 20 EU/device.90 Thus, it is of utmost 
importance to comply with these guidelines to guarantee the non-pyrogenicity of biomaterials. 
 
The potential use of BNC as a scaffold material for auricular cartilage regeneration requires, first 
and foremost, the depyrogenation of the material. Previous studies have only reported 
purification methods for thin BNC scaffolds (i.e. 0.2 to 3 mm in thickness) and have not 
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systematically evaluated the removal of endotoxins from the BNC network.32,34,75-77,91,92 There 
are various depyrogenation methods ensuring endotoxin inactivation and removal.93-95 In this 
context, treatment of BNC with aqueous sodium hydroxide solution, followed by rinsing with 
deionized water is the most common depyrogenation method reported in literature. In large BNC 
scaffolds, such as an auricle, the purification process is challenged by the higher bioburden and 
slower transport of bacterial residues compared to the thin and highly porous BNC scaffolds 
previously evaluated for various tissue engineering applications. Thus, it is of utmost importance 
to develop and validate an effective depyrogenation process for large BNC scaffolds before any 
in vivo studies are conducted.  
 
2.6 3D Bioprinting of tissue analogues 
 
A major challenge in tissue engineering has been the limitation of the widely used production 
methods to generate cell-seeded scaffolds with structures that mimic the target tissue, both in 
anatomic geometry and intra-tissue architecture with controlled spatial cell distribution. The 
characteristic of a material to be shaped into anatomical, patient-specific structures with high 
shape fidelity is considered a significant quality for any potential biomaterial in auricular 
cartilage TE.18,19,22 Of equal importance is to control the inner micro- and macro-scale features of 
the engineered-tissue to obtain satisfying aesthetic and functional results. In response to this need, 
more than a decade ago, advances in additive manufacturing inspired scientists to employ this 
technology for organ bioprinting and tissue engineering strategies.96-98 Bioprinting, an additive 
manufacturing technology, has gained due attention for its ability to spatially control the 
placement of cells, biomaterials and biological molecules.99,100 Bioprinting 3D tissue analogues 
provides the possibility of combining living tissue-specific cells with appropriate materials—
natural, synthetic or decellularized ECM hydrogels—in a defined and organized manner. 
Consequently, this technology offers endless possibilities to the future of tissue and organ 
regeneration, basic research and drug screening.101-104 Moreover, this technology allows the 
biofabrication of biomimetic-shaped three-dimensional (3D) structures unique to the target tissue 
or organ, since it can be combined with CAD/CAM technology using patients' medical 
images.105,106 Despite the challenges encountered when bioprinting hydrogel materials of low 
viscosity,107-109 considerable advances have been made to bioprint complex cell-laden 3D tissue 
constructs.103,110-116 However, the biofabrication of biomimetic-shaped 3D structures with high 
resolution, mimicking the intricate inner architecture unique to the target tissue, still remains a 
challenge.101,102,104 The development of hydrogel bioinks with good printability and bioactive 
properties that guide cellular fate processes would contribute to translation of this promising 
technology into the clinic. 
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CHAPTER 3 
 
3 AIMS OF THE THESIS 
Most auricular cartilage TE strategies have revolved around biodegradable scaffolds, where the 
hypothetical optimum has been the scaffold’s degradation orchestrated by the neo-tissue 
formation. It would be ideal if the scaffold could be degraded by the time the neocartilage has 
reached full mechanical strength. However, fine-tuning this intricate play has proven to be a 
challenge in TE. Problems concerning poor structural integrity of the implant could be solved 
using non-degradable biocompatible scaffold materials, such as bacterial nanocellulose, in order 
to retain the shape of the auricle after implantation. We aim for a hybrid implant—BNC well 
integrated with the host and neo-tissue—that supports cell ingrowth, neocartilage formation and 
long-term structural integrity after implantation. The overall aim of this thesis is to design and 
biofabricate non-degradable, biocompatible, patient-specific BNC scaffolds for use in auricular 
cartilage regeneration. 
3.1 Specific aims 
• Determine the biomechanical specifications for auricular cartilage replacement materials. 
Assess whether 1) BNC’s properties can be tuned to reach mechanical properties of 
relevance for auricular cartilage replacement materials, and 2) BNC can be produced in 
patient-specific auricular shapes. 
• Develop and validate a depyrogenation process for BNC scaffolds that complies with the 
guidelines set by the FDA for endotoxin limits in medical devices. Then, assess the in 
vitro and in vivo biocompatibility of purified and densified BNC hydrogels according to 
standards set forth in ISO 10993. 
• Evaluate the redifferentiation capacity of human nasoseptal chondrocytes cultured in 
porous BNC-Alginate composite scaffolds.  
• Design and fabricate a scaffold that integrates mechanical stability and high porosity to 
maintain a long-term structural integrity while providing a porous architecture that 
supports cell ingrowth and neocartilage formation. Develop methods to produce patient-
specific auricular BNC scaffolds with bilayer architecture. Evaluate neocartilage 
formation and stability of the bilayer BNC scaffolds in vitro and in vivo—in 
immunocompromised and immunocompetent animal models. 
• Evaluate 3D bioprinting as an automated biofabrication process of patient-specific, 
chondrocyte-laden auricular constructs using a bioink composed of nanofibrillated 
cellulose and alginate. Furthermore, evaluate the effect of this bioink on cellular response, 
proliferation, and neocartilage formation in chondrogenic conditions in vitro. 
• Re-design a compression bioreactor and evaluate the effect of dynamic mechanical 
stimulation to cell-seeded BNC constructs on neo-tissue development in vitro. 
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CHAPTER 4 
 
4 MATERIALS AND METHODS 
Please refer to Papers I-V for a more detailed description of materials and methods used in this 
thesis. 
4.1 Biosynthesis of bacterial nanocellulose 
 
Cellulose-producing bacteria strain Gluconacetobacter xylinus  (ATCC® 700178™) was used in 
Papers I, II, III and V and other unpublished work. The culture media used was fructose media 
with addition of corn steep liquor, as it has been shown in previous studies to be the most 
suitable.117 The culture media contains fructose (40 g/L), yeast extract (5 g/L), (NH4)2SO4 (3.3 
g/L), KH2PO4 (1 g/L), MgSO4⋅7H2O (0.25 g/L), corn steep liquor (20 mL/L), trace metal solution 
(10 mL/L) and vitamin solution (5 mL/L) in 1 liter of distilled water, pH 5.5. The trace metal 
solution consists of (mg): FeSO4·7H2O (3.60), CaCl2·2H2O (14.70), Na2MoO4·2H2O (2.42), 
ZnSO4·7H2O (1.73), MnSO4·5H2O (1.39), CuSO4·5H2O (0.05) and EDTA (3) in 1 liter of 
distilled water, pH 5; and the vitamin solution (mg): inositol (2.0), nicotinic acid (0.4), pyridoxine 
hydrochloride (0.4), thiamine hydrochloride (0.4), D-pantothenic acid calcium (0.2), riboflavin 
(0.2), p-amino benzoic acid (0.2), folic acid (0.0002) and d-biotin (0.0002) in 1 liter of distilled 
water, pH 5. For pre-cultivation, 6 cellulose-forming colonies were cultured for 2 days at 30 °C 
in a tissue culture flask (75 cm2, working volume of 50 ml). The bacteria were liberated from the 
cellulose network by vigorous shaking and inoculated into the culture media. The culture time 
was varied depending on the desired thickness of the BNC pellicle. 
 
4.2 Mechanical evaluation of bacterial nanocellulose as an implant material for auricular 
cartilage replacement 
 
In Paper I we investigated the potential use of BNC in auricular cartilage tissue engineering. 
Firstly, the mechanical properties of human auricular cartilage were measured in order to set a 
preliminary benchmark for auricular cartilage replacement materials. Secondly, the capacity of 
BNC to match these requirements was assessed. Finally, a novel biofabrication process to 
produce patient-specific auricular BNC implants was developed (Figure 3). Two distinct 
mechanisms are involved in the response of cartilage to loading: the intrinsic mechanical 
properties of the ECM and the resistance to interstitial fluid flow through the ECM,143 which is 
governed by the permeability and swelling pressure (Donnan osmotic pressure) of the ECM.118 
Creep and stress relaxation tests are commonly performed to characterize these properties, using 
confined or unconfined compression, as well as indentation testing.118,119 In Papers I, III and 
other unpublished work, stress-relaxation indentation testing was used to evaluate the mechanical 
properties of native cartilage, densified BNC hydrogels and tissue-engineered constructs. In an 
indentation test, a porous or non-porous indenter is used to indent the sample. The diameter of the 
indenter is chosen to allow fluid flow, while the sample is confined radially. Indentation can be 
performed at different locations of the same sample, so as to evaluate spatial variation in 
mechanical properties.120 
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Figure 3 – Graphical abstract of Paper I. Firstly, the mechanical properties of human auricular cartilage were 
measured. Secondly, the capacity of BNC to match these requirements was assessed. Finally, a novel biofabrication 
process to produce patient-specific auricular BNC implants was developed. 
4.2.1 Harvesting of human auricular cartilage 
Human auricular cartilage samples were obtained according to the ethics regulations of the 
University Hospital Zurich (Zurich, Switzerland), the Ulm University Medical Center, (Ulm, 
Germany) and the Erasmus Medical Center, (Rotterdam, The Netherlands). Samples were either 
harvested from patients undergoing ear reconstructive surgery or from complete auricles obtained 
post mortem from human donors. Prior to testing, the perichondrium was removed to expose the 
cartilage surface. 
 
4.2.2 Preparation of densified bacterial nanocellulose hydrogels 
First, large BNC cylinders were biosynthesized in static culture for 30 days, until the bacteria had 
produced large cylindrical BNC structures with height of approximately 5 cm. The protocol used 
to remove the bacteria and its residues from the cellulose matrix was adapted from previous 
studies.32,80 In brief, the BNC cylinders were washed in 0.1 M NaOH for 21 days, changing the 
solution every day, and then rinsed with large amounts of deionized water to remove bacterial 
residues and neutralize the pH. BNC pellicles with varying nominal cellulose content of 2.5%, 
5%, 7.5%, 10%, 12.5% and 15% were produced by compressing BNC cylinders with different 
initial heights down to a final height of 1 mm, as described in Paper I. 
 
4.2.3 Mechanical testing 
BNC samples (n = 78) with varying nominal cellulose content (2.5–15%) were compared using 
stress-relaxation indentation with human auricular cartilage (n = 17, from 4 males, aged 49–93 
years old). Samples were placed in close-fitting stainless steel cylindrical wells. Mechanical 
testing was performed with a materials testing machine (Zwick Z005) equipped with a 10 N load 
cell, a built-in displacement control, and a cylindrical, plane ended, stainless steel indenter 
(∅0.35 mm). Measurements of maximum stress (σmax), equilibrium modulus (Eeq), and 
Mechanical)integrity)
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instantaneous modulus (Ein) were determined for every sample, as described previously.120 
Additionally, a relaxation half-life time (t1/2) and a characteristic relaxation time (τ) were 
computed to estimate the viscoelastic relaxation after the first strain application. 
 
4.3 Biofabrication of patient-specific auricular bacterial nanocellulose implants 
 
In Paper I, we also presented a novel biofabrication process to produce patient-specific BNC 
implants with complex 3D shapes. A bioprinter, consisting of a high precision micro-dispensing 
system, used to dispense controlled volumes of culture media, and a precision motion system, 
used to control the dispensing location, was developed in-house for the biofabrication of a 
patient-specific auricular BNC implant prototype. First, the auricle of a volunteer was segmented 
and reconstructed from magnetic resonance imaging (MRI) data and subsequently 3D rapid 
prototyped using selective laser sintering. A negative auricle mold, produced by casting silicone 
around the auricle model, was inoculated with bacteria suspension and positioned in the 
bioprinter to guide the bacteria to reproduce the large-scale features of the auricle. Meanwhile, 
the micro-dispensing valve was programmed to spray sterile culture media into the mold every 6 
hours. The 3D biofabrication process continued for 18 days, until the cellulose layer filled the 
silicone mold. The auricular BNC implant prototype was removed from the mold and cleaned 
following the same protocol described for the BNC pellicles. 
 
4.4 Biocompatibility evaluation of densified bacterial nanocellulose hydrogel 
 
In Paper II, we investigated the biocompatibility of densified BNC hydrogel with cellulose 
content of 17%. First, cylindrical BNC structures (Ø48 × 20 mm) were produced, purified in a 
built-in house perfusion system, and compressed to increase the cellulose content in the BNC 
hydrogels (densification of BNC described in Paper I). The reduction of endotoxicity of the 
material was quantified by bacterial endotoxin analysis throughout the purification process. 
Afterward, the biocompatibility of the purified dense BNC hydrogels was assessed in vitro and in 
vivo, according to standards set forth in ISO 10993. It was hypothesized that biocompatibility of 
BNC should not be affected after densification of the nanocellulose network, provided that 
endotoxin levels in the BNC network are below the endotoxin limit (0.5 EU/ml) set by the FDA 
for medical devices.90 
 
4.4.1 Depyrogenation process 
The potential use of BNC as a scaffold material for auricular cartilage regeneration requires, first 
and foremost, the depyrogenation of large BNC structures before the compression and 
densification of the BNC network is done. Previous studies have only reported purification 
methods for thin BNC scaffolds (i.e. 0.2 to 3 mm in thickness) and have not systematically 
evaluated the removal of endotoxins from the BNC network.32,34,75-77,91,92 Thus, in Paper II, we 
developed and validated a depyrogenation process for large BNC structures. The depyrogenation 
of BNC consisted of two purification steps (see Figure 4). The first step involved washing the 
BNC cylinders with 0.5 M NaOH in a built-in house perfusion system to speed up the removal of 
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bacteria and endotoxins from the BNC network. The second step involved washing the 
densified BNC hydrogel disks in sterile and non-pyrogenic conditions using endotoxin-free water 
with an endotoxin specification of <0.005 EU/ml. 
 
 
Figure 4 −  Overview of depyrogenation of densified BNC before biocompatibility evaluation. (a) The first 
depyrogenation process consisted in washing large BNC cylinders with 0.5M NaOH in a built-in-house perfusion 
system (schematic) for 28 days in a non-sterile environment. The perfused BNC cylinders were then compressed to 
increase the cellulose content. (b) The second depyrogenation process consisted in washing the densified BNC disks 
with endotoxin-free water for 14 days in sterile conditions. (Paper II) 
4.4.2 Validation of depyrogenation process 
The reduction in endotoxicity and cytotoxicity of BNC was monitored throughout the purification 
process. Densified BNC hydrogels were analyzed for surface chemical composition, endotoxin 
content, crystallinity and in vitro cytotoxicity. 
 
Electron spectroscopy for chemical analysis: In Paper II, surface chemical composition 
analyses were performed on BNC samples during the first purification process using a PHI 
Quantum 2000 scanning ESCA microprobe (Physical Electronics, MN, USA). The percent 
content of nitrogen, oxygen and carbon, as well as the signal peak for C–C bonds in the high 
resolution spectra were analyzed to monitor the 1) removal of bacterial and medium residues, 
shown by the reduction of nitrogen; 2) removal of LPS molecules, shown by the reduction of the 
signal peak for C–C bonds; and 3) purity of the material, indicated by the oxygen to carbon ratio 
of 0.83 which is found in pure cellulose. 
 
Bacterial endotoxin testing: An endotoxin-mediated pyrogen test was performed on extracts of 
scaffolds studied in this thesis to evaluate the potential of the materials to induce a pyrogenic 
response (fever). This test can be performed in vitro using the bacterial endotoxin test, or in vivo 
using a rabbit model; the former method was selected in this work. Endotoxin extraction from the 
BNC scaffolds was done in accordance to the international standard ISO 10993-12:2009. 
Samples were incubated in endotoxin-free water, using the extraction ratio of 0.1 g of BNC/ml of 
extraction medium, for 72±2 hours at 37±1 °C under orbital motion. Endotoxicity of the extracted 
samples was determined by the PyroGene™ recombinant Factor C assay performed by Lonza 
Verviers (Papers II, III and other unpublished work). This assay has a minimum detection limit 
of 0.005 EU/ml. 
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X-ray diffraction: In Paper II, the crystallinity of the purified BNC was investigated with XRD 
to analyze any possible changes in the crystalline structure of BNC fibrils caused during the 
purification process. The crystallinity was analyzed with a Siemens D5000 X-ray diffractometer. 
The relative crystallinity index (CrI) was calculated by Segal’s method,121 using the equation CrI 
= (I200−Iam)/I200×100, where I200 is the peak intensity of the (200) plane at 2θ = 22.6° for cellulose 
I, and Iam is the peak intensity of the amorphous fraction at 2θ=18° for cellulose I. 
 
In vitro cytotoxicity testing: In Papers II-IV, the studied scaffold materials were tested 
according to the international standard ISO 10993-5:2009 (Biological evaluation of medical 
devices–Part 5: Tests for in vitro cytotoxicity) to determine the biological response of 
mammalian cells in vitro. This test is a common cytotoxicity assessment designed to assess the 
toxicity to cells of leachable components of the material. The material is extracted in cell culture 
media. Extracts are placed in contact with a monolayer of L929 mouse fibroblast cells. Cells are 
incubated in standard culture conditions for an additional period of time, after which they are 
examined for indications of cytotoxicity. CellTiter 96® aqueous one solution cell proliferation 
assay (Promega, WI, USA) was used to determine the number of viable cells. The cytotoxic 
potential of the tested samples was identified based on the percentage of cell viability; classified 
as toxic when cell viability was below 50%, slightly cytotoxic when it was between 51% and 
70%, and non-cytotoxic when cell viability was above 71%. 
 
4.4.3 In vivo biocompatibility evaluation 
In Paper II, the in vivo biocompatibility of densified BNC hydrogels was assessed according to 
international standard ISO 10993-6:2009 (Biological evaluation of medical devices–Part 6: Tests 
for local effects after implantation). An in vivo intradermal reactivity test was performed to 
determine adverse biological reactions caused by the implanted BNC material. All experiments 
were carried out in accordance with European guidelines for the Care and Use of Laboratory 
Animals and performed with the approval of the Regional Ethical Board in Tübingen, Germany. 
The intradermal implantations were conducted on female Chinchilla Bastard rabbits (Charles 
River Laboratories). In this study, we established three experimental groups (Table 1). The first 
group was implanted with autologous auricular cartilage (control group), since it is the gold 
standard in auricular cartilage reconstruction. The second group was implanted with densified 
BNC hydrogel disks, whereas the third group was implanted with medical grade Gore-Tex 
matrices (Gore-Tex® Soft Tissue Patch, expanded polytetrafluoroethylene), since it is considered 
an inert biomaterial. After 1 week in vivo retention time, animals were terminated and samples 
were explanted for examination of macroscopic and microscopic tissue responses.  
 
Table 1 - Experimental groups and number of implants per group. 
Group Implant Animals/group Implants/animal 
1 Autologous auricular cartilage 3 4 
2 Densified BNC hydrogel 3 4 
3 Medical grade GoreTex® 3 4 
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4.4.3.1 Histopathological evaluation of biocompatibility index 
A semi-quantitative scoring system was used to analyze hematoxylin and eosin stained sections 
of explants for inflammatory and fibrotic reactions, according to the recommendations of ISO 
10993-6 appendix E. Inflammatory reactions were evaluated according to the presence of 
neutrophil polymorphonuclear cells (PMNC), lymphocytes, plasma cells, macrophages, giant 
cells, and necrosis. The fibrotic reaction was evaluated according to the presence of 
neovascularization, fibrosis, and fatty infiltration. On the basis of tissue and cellular responses, 
we determined the biocompatibility index (Bi) of the densified BNC hydrogel and control groups. 
The Bi was defined as the sum of the scores from the inflammatory and fibrotic reactions. Based 
on the Bi of each implant group, an irritant ranking was determined for each implant group: non-
irritant (0.0–2.9), slight irritant (3.0–8.9), moderate irritant (9.0–15.0), and severe irritant (>15.1). 
 
4.5 Bacterial nanocellulose and alginate as scaffold materials for auricular cartilage 
regeneration 
 
Native BNC hydrogels are impenetrable to cells due to the lack of macroporosity in the material. 
However, there are several methods available to create macroporous BNC scaffolds that support 
cell ingrowth.75,76,85 The redifferentiation capacity of culture-expanded human nasoseptal 
chondrocytes was studied in BNC-Alginate (BNC-A) composite scaffolds in vitro, where the 
effect of scaffold composition on neocartilage formation was evaluated. Two groups of BNC-A 
composite scaffolds, 50/50 and 90/10, with similar macro-architecture but different surface 
topographies were investigated. 
 
4.5.1 Fabrication and characterization of BNC-Alginate composite scaffolds 
Macroporous BNC-A composite scaffolds were fabricated by a freeze-drying process, as 
described in Paper III. First, thin BNC pellicles were produced and cleaned as described in 
Paper V. The BNC pellicles were then homogenized, until a pulp consistency was achieved, and 
steam sterilized. Different amounts of 1.1 % (w/w) sterile sodium-alginate solution were mixed 
with sterile BNC suspension to achieve two different ratios (BNC/Alginate: 50/50 and 90/10), 
expressed as percent dry weight of BNC and alginate compared to the total dry weight. 
Subsequently, the BNC-A mixtures were dispersed, frozen to −80 °C and lyophilized to 
sublimate the ice crystals and create a macroporous architecture. BNC-A composite scaffolds (Ø5 
mm × 2 mm) were cut and stabilized by crosslinking the alginate with 100 mM CaCl2 solution. 
Prior to cell culture, BNC-A composite scaffolds (each n = 87) were sterilized in 70% ethanol for 
30 minutes. 
 
Endotoxin levels in the BNC-A composite scaffolds were measured using the Limulus amebocyte 
lysate (LAL) test. The LAL test was performed in triplicate using the Endosafe®-PTS™ assay 
(Charles River Laboratories). Endotoxin extraction was performed as described in section 4.4.2. 
Furthermore, in vitro cytotoxicity of BNC-A composite scaffolds was tested according to ISO 
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10993-5, as described in section 4.4.2. Finally, the micro- and macro-structure of BNC-A 
composite scaffolds was characterized using a Leo Ultra 55 field-emission gun SEM (Carl Zeiss). 
 
4.6 Bilayer bacterial nanocellulose scaffold for auricular cartilage regeneration 
 
In Paper III we investigated the in vitro and in vivo performance of a novel bilayer BNC 
scaffold, composed of a dense BNC layer (Paper II) joined with a macroporous composite layer 
of BNC and alginate, designed to be mechanically stable and maintain a long-term structural 
integrity while providing a porous architecture that supports cell ingrowth and neocartilage 
formation. 
 
4.6.1 Fabrication and purification of bilayer BNC scaffold 
Densified BNC hydrogel disks (i.e. dense layer) were produced and purified as described in 
Papers I and II, respectively. Whereas 90/10 BNC-A composite scaffolds (i.e. porous layer) 
were fabricated by a freeze-drying process, using non-pyrogenic BNC. In Paper III we used a 
novel cellulose solvent system, consisting of the ionic liquid EMIMAc (1-ethyl-3-
methylimidazolium acetate), to achieve a strong interfacial molecular bonding between the dense 
and porous layers. Bilayer BNC scaffolds were crosslinked with 100 mM CaCl2 solution and then 
washed in sterile and non-pyrogenic conditions to remove cytotoxic EMIMAc residues and 
endotoxins. Subsequently, the purified bilayer BNC scaffolds (Ø8 mm × 3 mm) were steam 
sterilized in endotoxin-free water. 
 
4.6.2 Validation of purification process and characterization of scaffold 
Removal of EMIMAc residues from the bilayer BNC scaffolds was evaluated by infrared 
spectroscopy analysis (ATR-FTIR). The peak at wavenumber 1566 cm-1 was used to detect 
EMIMAc residues in the ATR spectra of bilayer BNC scaffolds. This peak is composed of two 
overlapped peaks that correspond to the carboxyl group of the acetate and an underlying ring 
mode of the cation, as shown by previous studies.122,123 Furthermore, the removal of cytotoxic 
EMIMAc residues and endotoxins from the bilayer BNC scaffolds was evaluated by in vitro 
cytotoxicity testing and by the PyroGene™ recombinant Factor C assay, respectively (see section 
4.4.2). Moreover, the morphology of bilayer BNC scaffolds was characterized by SEM and 
micro–computed tomography (microCT). 3D morphometric parameters such as scaffold porosity 
and mean pore size were computed from microCT reconstructions of the porous BNC-A scaffold 
layer. 
 
4.7 Patient-specific bacterial nanocellulose scaffold for auricular cartilage regeneration. 
 
We continued the development of a patient-specific auricular BNC scaffold with a bilayer 
architecture that integrates mechanical stability and high porosity (Paper III). In this study we 
investigated the in vivo performance of auricular BNC scaffolds in an immunocompetent animal 
model. 
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4.7.1 Fabrication and purification of patient-specific auricular BNC scaffold 
Patient-specific auricular BNC scaffolds (n = 12), composed of a dense and porous layer, were 
fabricated by combining the methods developed in Papers I-III. First, auricular cartilage of a 
volunteer was reconstructed from MRI data, scaled to 60% of original size and then the 3D model 
was rapid prototyped, as described in Paper I. A negative auricular mold, produced by casting 
silicone around the auricular cartilage model and which consists of a top and bottom part, was 
used to mold already compressed BNC pellicles into auricular cartilage-shaped structures (dense 
BNC layer). Meanwhile, 90/10 BNC-A composite scaffolds (Ø52 mm × 2 mm) were fabricated 
by a freeze-drying process, then crosslinked with 100 mM CaCl2 solution and rinsed with sterile 
water. The wet BNC-A porous layer was placed on the dense BNC layer and the top part of the 
mold was used for molding the porous layer. Both scaffold layers were frozen to −80 °C 
overnight while being supported by the mold, then detached from the mold and freeze-dried. The 
ionic liquid EMIMAc was used to achieve a strong interfacial molecular bonding between the 
dense and porous layers, as described in Paper III. Auricular BNC scaffolds were then purified 
in sterile and non-pyrogenic conditions, as described in Paper III, for up to 8 weeks. 
Subsequently, the purified auricular BNC scaffolds were steam sterilized. Removal of endotoxins 
and cytotoxic ionic liquid residues from the auricular BNC scaffolds was evaluated by the 
PyroGene™ recombinant Factor C assay and in vitro cytotoxicity testing, respectively (see 
section 4.4.2). 
 
4.8 3D bioprinting of human chondrocyte-laden nanocellulose hydrogel for patient-specific 
auricular cartilage regeneration 
 
In Paper IV we evaluated the biological functionality of a nanocellulose-based bioink for 
auricular cartilage TE. 3D bioprinted auricular constructs, laden with human chondrocytes, were 
cultured for up to 28 days to study the redifferentiation capacity of the chondrocytes. 
 
4.8.1 Preparation and cytotoxicity evaluation of NFC-Alginate bioink 
A highly viscous, shear-thinning dispersion of nanofibrillated cellulose (NFC) was provided by 
Innventia AB (Sweden) and produced as described by Pääkkö et al.124 The NFC dispersion was 
concentrated to 3 % (w/w) and mannitol was dissolved at a concentration of 4.6 % (w/w). The 
mixture was loaded in syringes and sterilized by electron irradiation at a dose of 25 kGy. Sterile 
alginate (FMC BioPolymer AS, Norway) was dissolved in 4.6 % (w/w) sterile-filtered mannitol 
solution at a concentration of 30 mg/ml. The NFC dispersion and alginate solution were then 
combined at a volume ratio of 4:1 (NFC:Alginate) and mixed thoroughly with a spatula, under 
sterile conditions. In vitro cytotoxicity of the NFC-Alginate (NFC-A) bioink was tested according 
to ISO 10993-5. 
 
4.8.2 Bioprinting of cell-laden NFC-Alginate bioink into auricular and gridded structures 
A 3D model of a human auricle reconstructed from an MRI scan (described in Paper I) was used 
for the bioprinting experiment. Using a 3D Discovery® instrument (regenHU Ltd, Switzerland), 
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chondrocyte-laden NFC-A hydrogel constructs were bioprinted in the shape of a human auricle 
and gridded structures. After bioprinting, the cell-laden NFC-A constructs were immediately 
crosslinked with 100 mM aqueous CaCl2 solution and cultured in standard culture conditions (see 
section 4.11.1) 
 
4.9 Mechanical stimulation of cell-seeded BNC scaffolds to enhance neo-tissue development 
 
In Paper V, cell-seeded macro-channeled BNC scaffolds were cultured under dynamic 
mechanical stimulation in a compression bioreactor to enhance collagen production by the cells. 
In this study, the mouse fibroblast 3T6 cell line was used as a model, as it is a robust collagen 
secreting line. The in vitro culture of cell-seeded scaffolds under mechanical stimulation 
consisted of two phases. The constructs were first cultured under static conditions for 14 days, 
followed by dynamic stimulation conditions in a built in-house compression bioreactor for 14 
days. The constructs were subjected to a dynamic compression of 5% at a loading frequency of 
0.1 Hz, during a 10-min period followed by a 15-min pause, for a total duration of 5 h/day. These 
loading conditions fall in the range of the physiological conditions relevant for native cartilage 
tissue (0.1–1 Hz, 5–10% strain).125,126 A static culture was used as control. The three-dimensional 
distributions of collagen fibers and fibroblasts in the cellulose scaffolds were studied under 
native, soft-matter conditions by combined second harmonic generation (SHG) and coherent anti-
Stokes Raman scattering (CARS) microscopy. Collagen type I127 and cellulose128 fibers can be 
visualized by SHG microscopy. With CARS microscopy, visualization of cell arrangement can 
be done by probing a hydrogen-carbon vibration of CH2 groups present in cell membranes and 
storage lipids.129 
 
4.10 Cell culture 
 
4.10.1 Cell source 
Human nasoseptal chondrocytes (hNC) were used in Papers III and IV. Nasoseptal cartilage 
biopsies were obtained during routine surgeries, like rhinoplasty or septorhinoplasty, at the 
Department of Otorhinolaryngology, Ulm University Medical Center (Ulm, Germany). Cartilage 
harvesting was approved by the University of Ulm ethics committee (No. 152/08), and all 
patients involved in this research responded to an informed consent. Donor age ranged from 22 to 
54 years. 
 
In Paper III, culture-expanded hNCs as well as a combination of freshly isolated (uncultured) 
hNCs and human bone marrow mononuclear cells (MNC) were used. Nasoseptal cartilage 
biopsies were obtained from male and female patients (mean age 31 years; age range 18–69 
years) undergoing routine reconstructive septorhinoplasty at the Department of 
Otorhinolaryngology, Ulm University Medical Center, with approval of the local medical ethics 
committee (No. 152/08). The cartilage biopsies were divided in three pools prior to the isolation 
of hNCs.  Additionally, bone marrow aspirate was collected from three donors (mean age 70 
years, 2 males, 1 female) during total hip replacement surgery at the Department of Orthopaedics, 
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Erasmus Medical Center (Rotterdam, The Netherlands), after acquiring written patient consent 
and approval of the local medical ethics committee (MEC-2004-142). Biopsies were sent to 
CellCoTec (Bilthoven, The Netherlands) for rapid isolation of hNCs and MNCs. 
 
Rabbit auricular chondrocytes (rAC) were used for the immunocompetent autologous graft. 
Auricular cartilage biopsies were harvested from the right auricle of New Zealand White (NZW) 
rabbits (Charles River Laboratories), after acquiring the approval of the Regional Ethical Board 
in Tübingen, Germany. 
 
4.10.2 Cell isolation and expansion 
Isolation of hNCs and rACs from the cartilage was done by enzymatic digestion of the tissue with 
0.3% type II collagenase in culture medium (DMEM/Ham’s F-12 supplemented with 10% FBS 
and 0.5% gentamycin) for 16-18 hours at 37 °C under agitation. Cells were separated by filtration 
through a 100-µm cell strainer and resuspended in culture medium. Total cell number and 
viability were determined using the trypan blue exclusion method. Subsequently, the hNCs and 
rACs were seeded for expansion in monolayer culture at a density of 5,000 cells/cm2. When 
reaching 80%–90% confluence, hNCs were detached, counted, and cryopreserved to ensure an 
equal treatment for all cells harvested from different donors. rACs and hNCs were expanded one 
more week in monolayer culture to obtain a sufficient cell number, where medium was changed 
three times per week. When reaching 80%–90% confluence, cells were detached, counted and 
resuspended in culture medium at the desired cell concentration. All experiments were conducted 
using hNCs and rACs at passage 2.  
 
In Paper III (in vivo study), a combination of freshly isolated (uncultured) hNCs and MNCs was 
used. The rapid isolations of hNCs and MNCs were performed by CellCoTec. Patented clinically 
applied protocols were used to isolate the cells within the hour.130 In brief, cartilage pieces were 
digested enzymatically under mechanical stimulation. Upon rapid digestion, any remaining debris 
was filtered out with a cell strainer. For the collection of MNCs, the bone marrow aspirate was 
relieved of its erythrocyte content using lysis buffer. Standard cell buffer was used for washing 
steps. Cell numbers and viability were measured using the trypan blue exclusion method. 
 
4.11 Chondrogenic differentiation 
 
4.11.1 Chondrogenic differentiation in vitro 
Prior to cell seeding, BNC-A composite scaffolds and bilayer BNC scaffolds (Paper III) were 
conditioned in culture medium and chondrogenic medium, respectively, for 24 h. All incubations 
were done in standard culture conditions (37 °C, 5% CO2 and 95% relative humidity). 
Subsequently, hNCs were seeded in the scaffolds at a cell density (cells/apparent scaffold 
volume) of 25×106 cells/cm3 (BNC-A composite scaffolds) and 10×106 cells/cm3 (bilayer BNC 
scaffolds). In Paper IV, hNCs were encapsulated in NFC-A bioink at a concentration of 20×106 
cells/ml. After bioprinting and crosslinking, the hNC-laden NFC-A constructs were rinsed with 
culture medium. HNCs were cultured in defined chondrogenic medium (StemMACS 
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ChondroDiff media) containing recombinant analog of insulin-like growth factor-I (R3 IGF-1), 
transforming growth factor beta 1 (TGF-β1), insulin, transferrin, L-glutamine and FBS. The 
addition of IGF-1 and TGF-β1 enhances chondrogenic differentiation and stimulates the 
synthesis of cartilage–specific ECM. Furthermore, IGF-1 decreases matrix catabolism 
(destructive metabolism) and TGF-β1 decreases catabolic activity of numerous catabolic 
cytokines, including interleukin 1 (IL-1) and matrix metalloproteinases (MMPs).131-136 
Chondrogenic differentiation in hNC-seeded/laden scaffolds was studied in vitro for six weeks 
(BNC-A composite scaffolds and Paper III) and four weeks (Paper IV) in standard culture 
conditions. 
 
4.11.2 Chondrogenic differentiation in vivo 
Chondrogenic differentiation in cell-seeded scaffolds was also studied in vivo. The first in vivo 
study was performed in an immunocompromised animal model for eight weeks (Paper III), and 
the second study was performed in an immunocompetent animal model for six weeks with 
patient-specific auricular BNC scaffolds. 
 
4.11.2.1 Implantation of constructs in immunocompromised animal model 
In Paper III, we explored the application of a clinically relevant strategy, seeding a low number 
of freshly isolated human chondrocytes in combination with freshly isolated human mononuclear 
cells, in order to test the translation of this auricular cartilage TE technology to the clinic. Cells 
were first encapsulated in alginate as a combination of 80% freshly isolated MNCs and 20% 
freshly isolated hNCs at a total cell concentration of 20×106 cells/ml and subsequently seeded in 
bilayer BNC scaffolds. To evaluate the stability of the bilayer BNC scaffolds and neocartilage 
formation in a more complex biological environment, MNC/hNC-seeded and cell-free bilayer 
BNC scaffolds were implanted subcutaneously on the dorsal side of 9-week-old nude female 
mice (NMRI nu/nu, Charles River Laboratories). At the time of implantation, mice were 
anesthetized with 2.5% Isoflurane. Eight weeks after subcutaneous implantation, animals were 
terminated and samples were explanted for immunohistochemical, biochemical and 
biomechanical analyses. Animal experiments were carried out with approval of the local Animal 
Experiments Committee of the Erasmus Medical Center, Rotterdam, The Netherlands (EMC 
2429). 
 
4.11.2.2 Implantation of constructs in immunocompetent autologous model 
For the immunocompetent autologous tissue-engineered auricular graft, we used New Zealand 
White (NZW) rabbits (3 months old). Four weeks prior to implantation, rabbit auricular cartilage 
was harvested and isolated rACs were expanded in monolayer culture for 2 weeks. Prior to cell 
seeding, patient-specific auricular BNC scaffolds (n = 6) were conditioned in 3D-culture medium 
(high glucose DMEM supplemented with 50 µg/ml L-ascorbic acid, 2.5 µg/ml human insulin, 0.4 
mM L-proline, 10% FBS and 0.5% gentamicin) for 24 h. RACs were seeded into auricular BNC 
scaffolds (50×106 cells/cm3) and cultured for 2 weeks in vitro. Before the implantation, rAC-
seeded (n=6) and cell-free (n=6) scaffolds were rinsed with sterile saline solution to remove 
medium components, such as FBS, that could cause an unwanted inflammatory reaction. 
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Subsequently, the autologous grafts were implanted to the same rabbit donor. NZW rabbits 
(n=6) were anesthetized and the dorsum shaved. Through a 5 cm incision along the spine, each 
animal received subcutaneously a seeded (left side) and a cell-free (right side) auricular BNC 
scaffold. Animals received antibiotics and pain treatment for 3 days post-implantation. Six weeks 
after subcutaneous implantation, animals were terminated and samples were explanted for gross 
morphological, immunohistochemical and biomechanical analyses. All experiments were carried 
out at the Department of Otorhinolaryngology, Ulm University Medical Center, in accordance 
with European guidelines for the Care and Use of Laboratory Animals and approval of the 
Regional Ethical Board in Tübingen, Germany. 
 
4.12 Evaluation methods for chondrogenic differentiation 
 
4.12.1 Electron microscopy 
In order to study the interaction between the scaffold material and chondrocytes, cell morphology 
and ECM neo-synthesis in the scaffolds, scanning electron microscopy (SEM; Leo Ultra 55 field-
emission gun SEM) and transmission electron microscopy (TEM; Zeiss EM 10 and JEM-1400) 
analyses were performed.  
 
4.12.2  Histological analysis 
The cell-seeded scaffolds were fixed with 4% formaldehyde, embedded in paraffin and sectioned 
(5 µm). Formaldehyde is used to fixate the tissue by crosslinking the proteins, particularly 
between the lysine residues. The stainings used in the thesis are listed in Table 2. 
 
Table 2 – Short description of histological stainings used. 
Stain ECM component analyzed Comment 
Hematoxylin 
and Eosin 
(H&E) 
Extracellular matrix in general 
Proteins are stained red or pink and 
nuclei is stained dark blue. 
Hematoxylin binds to basophilic 
substances (e.g. DNA/RNA). 
Eosin binds to acidophilic 
substances (e.g. proteins). 
Alcian blue 
(AB) 
Sulfated glycosaminoglycans (s-
GAG), proteoglycans 
Cartilage is stained blue and nuclei 
black. 
Cationic dye that forms 
reversible electrostatic bonds 
with the negative sites of 
polysaccharides (s-GAG). 
Safranin O 
and fast green 
Proteoglycans 
Cartilage is stained orange to red, 
cytoplasm blue-green and nucleic 
black. 
Cationic dye that binds to 
negative sites of chondroitin-6-
sulfate or keratin sulfate–
components of cartilage. 
Verhoeff's 
stain 
Elastin 
Elastic fibers and nuclei are stained 
black. 
Verhoeff's stain forms a variety 
of cationic, anionic and non-
ionic bonds with elastin. 
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4.12.3 Immunohistochemical analysis 
In Papers III and IV and other unpublished work, cell-seeded scaffolds were processed for 
immunohistochemical (IHC) staining to detect cartilage–specific proteins such as aggrecan, type 
II collagen, cartilage oligomeric protein (COMP) and matrilin-3, and the dedifferentiation marker 
type I collagen. Positive immunostains were confirmed with the use of native ear or nasoseptal 
cartilage. A monoclonal mouse IgG1 antibody was used as a negative control. Sections were 
deparaffinized and dehydrated. An enzymatic antigen retrieval step followed by quenching of 
endogenous peroxidase activity was performed before incubation with primary antibodies. For 
visualization of these markers the LSAB+System-HRP kit (Dako), which is based on the labeled 
streptavidin biotin method, was used according to the manufacturer’s protocol. The color reaction 
was developed using DAB and AEC chromogens, resulting in a brown or red precipitate at the 
antigen site, respectively. 
 
4.12.4 Gene expression analysis 
In Papers III and IV and other unpublished work, the capacity of hNCs to synthesize cartilage-
specific ECM components in the scaffolds was also investigated on the basis of the expression of 
the chondrogenic marker genes ACAN and COL2A1. The dedifferentiation markers, VCAN and 
COL1A1, were also investigated. Additionally, in Paper IV expression of chondrogenic markers 
such as SRY-box 9 (SOX9), cartilage oligomeric matrix protein (COMP) and matrilin-3 
(MATN3), and osteoblastic marker runt-related transcription factor 2 (RUNX2) were investigated. 
 
Isolation of RNA: Total RNA was extracted by disruption and homogenization of the hNC-
seeded scaffolds in lysis buffer. The RNA was isolated and purified using the RNeasy Mini kit 
and DNase mix according to the manufacturer’s instructions. The amount and quality of total 
RNA was quantified using a multimode microplate reader at 260 nm and 280 nm. The ratio of 
λ260/λ280 between 1.9 and 2.1 was considered an adequate marker for RNA purity. 
 
Real-time two-step RT-PCR analysis: Total RNA was converted to cDNA using QuantiTect 
Reverse Transcription kit, according to manufacturer’s protocol, in a thermocycler. Real-time 
PCR was performed using the LightCycler TaqMan Master kit and Universal Probe Library. The 
following genes were analyzed to study the redifferentiation of the chondrocytes: ACAN, 
COL2A1, SOX9, COMP, MTN3, VCAN, COL1A1 and RUNX2. Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) was used as housekeeping gene. Threshold cycle (CT) values were 
determined using a LightCycler 2.0 instrument. Relative gene expression was calculated using 
the 2-ΔCT or 2-ΔΔCT methods as described elsewhere.137,138 Using the 2-ΔCT method, the data is 
presented as the fold change in gene expression normalized to GAPDH (Paper III). Using the 2-
ΔΔCT
 method, the data is presented as the fold change in gene expression normalized to GAPDH 
and relative to human nasoseptal cartilage (Paper IV).  
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4.12.5 Biochemical analysis 
Glycosaminoglycan content: The proteoglycan content in the neocartilage produced by the hNCs 
was quantified using the 1,9-dimethylmethylene blue (DMMB) dye-binding assay. DMMB is a 
cationic dye that binds to sulfated glycosaminoglycans (s-GAG) and thereby changes in the 
absorption spectrum occur. For this assay to be suitable for cell cultures containing alginate, the 
DMMB pH level must be decreased to pH 1.5, as described by Enobakhare et al.139 In Paper III, 
the metachromatic reaction of the GAG-DMMB complex was measured spectrophotometrically 
at absorption ratios of 540 and 595 nm to determine the s-GAG content with chondroitin sulfate 
C as a standard.140 In Paper IV, the s-GAG content was measured according to the protocol by 
Barbosa et al.,141 which is based on the isolation and subsequent dissociation of the GAG-DMMB 
complex to render DMMB soluble. The absorption of the decomplexated DMMB is proportional 
to the GAG amount complexed from the original sample. The absorbance was measured at 656 
nm and the s-GAG content was calculated against a standard curve of chondroitin sulfate C. 
 
DNA content: Quantitation of DNA in hNC-seeded BNC-A composite scaffolds was performed 
using Hoechst 33258. Hoechst is a bisbenzimidiazole derivate that fluoresces when it binds to 
AT-rich regions of double stranded DNA. The DNA concentration was calculated against a 
standard curve of monolayer-cultured hNCs, as described elsewhere.142 In Paper IV, cell number 
per NFC-A hydrogel construct was measured using the QuantiFluor® dsDNA System (Promega). 
This system contains a fluorescent dsDNA-binding dye that enables sensitive quantitation of 
small amounts of double stranded DNA. Cell concentration was calculated against a standard 
curve of monolayer-cultured hNCs. 
 
Gelatine Zymography: In Paper IV, the expression and activity of the matrix metalloproteases 
MMP-2 (gelatinase A) and MMP-9 (gelatinase B) were determined by gelatine zymography. 
These enzymes control the matrix degradation of denatured collagen. Media samples were loaded 
on zymography gels and proteins were separated by electrophoresis. For evaluation of the MMPs, 
the volume intensity of the bands was corrected for the mean cell number per scaffold as 
determined by the QuantiFluor® dsDNA assay. 
 
4.12.6 Biomechanical analysis 
Stress-relaxation indentation testing was used to evaluate the mechanical properties of tissue-
engineered constructs (Paper III and auricular BNC scaffolds). Three samples were analyzed for 
each rAC-seeded and cell-free auricular BNC scaffold at 6 weeks post-implantation. Indentation 
was performed at two locations of the same sample, so as to evaluate spatial variation in 
mechanical properties.120 See section 4.2.3 for more details on the mechanical testing setup. 
 
4.13 Statistics 
 
In this thesis statistical analyses were performed using parametric and non-parametric statistical 
tests, depending on whether the data was normally distributed and had similar variance. In Paper 
I, a univariate analysis of variance (ANOVA) was used to test significant differences in the 
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measured mechanical parameters between densified BNC hydrogels and human auricular 
cartilage. The relationships between cellulose content and the measured mechanical parameters 
were evaluated using Pearson's linear regression coefficient of correlation. In Paper III 
comparison of means for the cytotoxicity and biomechanical analyses were assessed by one-way 
ANOVA and Tukey’s HSD test. When the data did not meet the requirements for a parametric 
test, the Kruskal-Wallis ANOVA on ranks was performed, followed by the Dunn’s test for post 
hoc comparisons (Papers II and IV). For comparing two groups, a two-sample Kolmogorov-
Smirnov test or Wilcoxon–Mann–Whitney test was performed (Papers III and IV). Values of p 
<0.05 were considered statistically significant. 
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CHAPTER 5 
 
5 RESULTS AND DISCUSION 
In this chapter the results from each paper and some unpublished work will be presented and 
discussed, starting with Paper I in section 5.1 and ending with Paper V in section 5.7. 
 
5.1 Evaluation of bacterial nanocellulose as an implant material for auricular cartilage 
replacement 
 
In Paper I143 we investigated the potential use of BNC in auricular cartilage tissue engineering. 
Firstly, the mechanical properties of human auricular cartilage were measured in order to set a 
preliminary benchmark for auricular cartilage replacement materials. Secondly, the capacity of 
BNC to match these requirements was assessed. Finally, a novel biofabrication process to 
produce patient-specific BNC implants was developed. 
 
5.1.1 Tuning the mechanical properties of bacterial nanocellulose to match the mechanical 
requirements of human auricular cartilage 
In this study, the mechanical properties (Ein, Eeq, σmax, t1/2 and τ) of human auricular cartilage 
were measured using stress-relaxation indentation. The following mechanical properties were 
determined: 6.4±3.2 MPa for Ein, 3.3±1.3 MPa for Eeq, 1.6±0.5 MPa for σmax, 2.1±1.3 s for t1/2 
and 6.0±2.6 s for τ (Figure 5). Moderate standard deviations are observed. These variations are 
expected to result from factors such as donor age, gender and harvesting location within the 
auricle. Since a detailed investigation of these factors was out of the scope of Paper I, these 
values represent a preliminary benchmark for BNC and other scaffold materials aimed at 
auricular cartilage TE. The mechanical characteristics of hyaline cartilage (e.g. articular cartilage, 
nasoseptal cartilage)144,145 and fibrocartilage (e.g. meniscus)146 are well documented, yet there is 
little data available for elastic cartilage (e.g. auricular cartilage).56 In comparison to hyaline and 
fibrocartilage, elastic cartilage contains significantly more elastin,56 which is known to be a 
highly resilient protein, and which plays a mechanically functional role in tissues like heart 
valves147 and skin.148 For this reason, a profile of the mechanical properties of auricular cartilage 
was required, since using published mechanical properties of hyaline cartilage or fibrocartilage 
may not be an appropriate substitute.  
 
Densified BNC hydrogels with cellulose content ranging from 4.1% up to 13.7% were 
characterized. The compressive mechanical properties (Ein, Eeq, and σmax) of densified BNC 
hydrogels were correlated to cellulose content with R values of 0.66, 0.79, and 0.78, respectively 
(p < 0.05 in all cases); demonstrating the tunability of the material (Figure 5). The computed 
correlation coefficients are moderate. Nonetheless, by varying cellulose content in BNC, an 
increase in Eeq from 0.06 to 3.2 MPa (at the highest cellulose content 13.7%) was observed; 
partly covering the range of values observed for auricular cartilage (3.3±1.3 MPa). The same 
observation holds for Ein and σmax. These parameters of tunability make BNC a promising 
candidate as a non-degradable implant material for auricular cartilage TE. 
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Despite observing a typical stress relaxation behavior in all BNC samples, the relaxation half-life, 
t1/2, of BNC (0.4 ± 0.1 s) was significantly less than auricular cartilage (2.1 ± 1.3 s; p < 0.05). 
The same observation was made for the characteristic relaxation time, τ (3.7 ± 1.0 s and 6.0 ± 2.6 
s, respectively; p < 0.05). As opposed to BNC, which is electrically neutral, cartilage contains 
charged groups by way of the GAG content in the ECM. These charged groups play a role in the 
relaxation behavior of cartilage, via charge-dependent osmotic swelling pressures enhanced 
during compression.143 Therefore, the introduction of electrical charge into the BNC network 
could provide mechanical properties that better mimic those of native cartilage, in particular 
improved relaxation kinetics (higher t1/2 and τ). In chondrocyte-seeded BNC constructs, the 
introduction of electrical charges could be achieved by the GAGs produced by the seeded cells. 
Alternatively, the presence of charged GAGs in BNC can be mimicked by chemical 
modifications such as sulfonation or phosphorylation of the material, as demonstrated by 
Svensson et al.81  
 
 
Figure 5 – (a) Instantaneous modulus, Ein, of BNC (ntotal = 78) correlates with cellulose content (R = 0.66), 6.4 ± 3.2 
MPa is measured for Ein of auricular cartilage (n = 17). (b) Equilibrium modulus, Eeq, of BNC correlates with 
cellulose content (R = 0.79), 3.3 ± 1.3 MPa is measured for Eeq of auricular cartilage. (c) Maximum stress, σmax, of 
BNC correlates
 
with cellulose content (R = 0.78), 1.6 ± 0.5 MPa is measured for σmax of auricular cartilage. (d) 
Relaxation half-life time, t1/2, of BNC is not influenced by the cellulose content, significant differences (p < 0.05) are 
observed between BNC and auricular cartilage (0.4 ± 0.1 s and 2.1 ± 1.3 s, respectively). (e) Characteristic 
relaxation time, τ, of BNC is not influenced by the cellulose content, significant differences (p < 0.05) are observed 
between BNC and auricular cartilage (3.7 ± 1.0 s and 6.0 ± 2.6 s, respectively).  (Paper I) 
SEM images of the network structure of native (1% cellulose content) and densified (5% and 
10%) BNC are shown in Figure 6. As expected, a denser BNC network is observed in the 
  
 
30 
hydrogels with higher cellulose content. This densification of the BNC network occurs mostly 
along the z-direction. That is, the spacing between the cellulose fibrils, in z direction, is reduced 
as the material is compressed and the water is forced out of the hydrogel. When the hydrogel is 
completely dried the nanocellulose fibrils coalesce, forming hydrogen bonds that crosslink the 
nanocellulose network. 
 
 
Figure 6 – SEM images of BNC with (a) 1%, (b) 5% and (c) 10% cellulose content. Densification of the BNC 
network occurs mostly along the z-direction. Spacing between the cellulose fibrils, in z direction, is reduced as the 
material is compressed and the water is forced out of the hydrogel. Width of dry nanocellulose fibrils is 
approximately 30 nm. (Paper I) 
5.1.2 Biofabrication of patient-specific auricular bacterial nanocellulose implants 
The auricular cartilage and external ear volume of a volunteer was successfully segmented and 
reconstructed from the MRI data (Figure 7a-b). A negative silicone mold was used to guide the 
bacteria during bacterial culture to reproduce the large-scale features of the outer ear; a process 
taking about 18 days (Figure 7c). Subsequently, a 3D patient-specific BNC implant prototype 
(1% cellulose content), mimicking the external ear shape, was successfully synthesized using this 
mold in a novel biofabrication process (Figure 7d). The auricular BNC implant prototype 
presented in Paper I demonstrates the ability of BNC to be shaped in more complex 3D 
structures than previously reported, i.e. blood vessels149-151 and meniscus.152 This was made 
possible through the use of a bottom-up biofabrication approach, which requires a mold to guide 
the bacteria to reproduce the large-scale features of the tissue of interest. The method described 
here is a novel biofabrication process of microbially grown 3D auricular scaffolds. 
 
It is key in the field of auricular cartilage replacement to control the external shape of the implant 
to obtain satisfying esthetic results. This outcome is often used as a measure of success for a 
potential biomaterial.18,19,22 Most efforts in auricular cartilage TE have used standardized 
auricular shapes.18,19,22,24 On the other hand, the auricular BNC implant prototype presented in 
this study was produced using patient MRI data, which yields a result compatible with the 
patient’s expectation. An alternative method for the fabrication of patient-specific auricular 
scaffolds was presented by Liu et al.65 who described the 3D printing of an auricular scaffold 
using computed-tomography data. The advantages of using MRI are, firstly the absence of 
potential radiation damage to the patient, and secondly a better soft tissue contrast and hence the 
direct visualization of cartilage. This makes it possible to produce patient-specific scaffolds that 
mimic the shape of auricular cartilage, rather than the whole outer ear (i.e. auricle). 
Consequently, in the following work we aimed at producing patient-specific BNC scaffolds with 
the shape of auricular cartilage. 
(a)$
1$µm$ 1$µm$ 1$µm$
(b)$ (c)$
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Figure 7 – (a) Transverse slice isolated from a spoiled gradient-echo MRI scan of volunteer’s left ear. Auricular 
cartilage is visible (dashed contour) surrounded by adipose tissue and skin. Plain contour indicates the external 
outline of the auricle. (b) 3D rendering of the auricle (gray color) and auricular cartilage (red color) obtained by 
manual segmentation of the previous MRI scan. (c) Negative silicone mold used to guide the bacteria during the 
bacterial culture to reproduce the large-scale features of the auricle. (d) Prototype of patient-specific auricular 
bacterial nanocellulose implant (1% cellulose content) produced using the dataset presented in (b). (Paper I) 
 
5.2 Biocompatibility evaluation of densified bacterial nanocellulose hydrogel 
 
In Paper I we found that the compressive mechanical properties (Ein, Eeq, and σmax) of densified 
BNC hydrogel with cellulose content of 13.7% covers the range of values observed for human 
auricular cartilage. Based on this, we propose BNC with high cellulose content (>14%) as a 
promising non-degradable implant material for auricular cartilage TE. In Paper II153  we 
investigated the host tissue response to this modified BNC material. Moreover, we considered of 
utmost importance to first evaluate the purity, pyrogenicity and cytotoxicity of the material, 
before an in vivo biocompatibility study was conducted. Thus, a purification and depyrogenation 
process was developed and validated. 
5.2.1 Validation of the depyrogenation process 
The first purification step in the built-in house perfusion system extensively removed bacteria and 
its residues, particularly endotoxins, from the large BNC cylindrical structures. As shown by the 
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results from ESCA, the perfusion of BNC cylinders with 0.5 M NaOH for 28 days effectively 
reduced bacterial and medium residues, indicated by the removal of nitrogen from 6.9 to 0 %; 
reduced endotoxins (i.e. LPS), indicated by the reduction of the signal peak for C–C bonds; and 
improved the purity of the material, indicated by the oxygen to carbon ratio of 0.83 as found in 
pure cellulose (Figure 8). A solution of 0.5 M NaOH was first used in the purification process to 
lyse bacteria, in order to release the LPS from the cell wall and to hydrolyze the eight carbon 
sugar that links the lipid A to the core oligosaccharide. This action causes the separated lipid A to 
reduce its pyrogenic activity.93,95 The results from bacterial endotoxin analysis verified the 
effectiveness of the perfusion system to remove endotoxins from large BNC structures. The 
endotoxin content in the non-purified BNC cylinders decreased from 2,390 to 17.7 EU/ml after 
14 days of perfusion and was further reduced to 5.7 EU/ml after 28 days of perfusion (Figure 9). 
Based on these results, we report a correlation between ESCA data on surface chemical 
composition and endotoxin content in BNC. 
 
 
Figure 8 – High-resolution ESCA spectra of (a) non-purified BNC and BNC perfused with 0.5M NaOH after (b) 14 
and (c) 28 days. The first depyrogenation process effectively reduced bacterial and medium residues, indicated by 
the removal of nitrogen from 6.9% to 0%; reduced lipopolysaccharides, indicated by the reduction of the signal peak 
for C-C bonds; and improved the purity of the material, indicated by the oxygen to carbon ratio of 0.83 as found in 
pure cellulose. (Paper II) 
The first depyrogenation process, involving the perfusion of large BNC cylinders with alkaline 
solution, was not able to reduce the endotoxins in the BNC network to levels below the endotoxin 
limit set by the FDA for medical devices.90 On the other hand, the second depyrogenation 
process, involving the rinsing of densified BNC hydrogel disks with endotoxin-free water for 14 
days, was shown to reduce the amount of endotoxins to 0.10 EU/ml; five times lower than the 
endotoxin limit (0.5 EU/ml) for medical devices (Figure 9). The result from endotoxin analysis 
verified the effectiveness of the second purification process to remove endotoxins from the 
densified BNC hydrogel disks. This latter process for depyrogenation of BNC has not been 
investigated previously as a method to complement the depyrogenation processes based on 
hydrolysis and oxidation. All studies reporting washing BNC with water as the final step to 
remove the alkali and neutralize the pH have used either DI or Milli-Q water32,34,76,77,91,92 except 
for one study which used endotoxin-free water to wash the BNC scaffolds after sterilization.75 
However, this is the first study that quantifies the reduction of endotoxins in BNC throughout the 
depyrogenation process, during perfusion with alkaline solution and after washing with 
endotoxin-free water, and reports endotoxin levels well below the limit for medical devices in 
BNC with cellulose content of 17 %. 
12121909.spe: none Pol teknologi
2012 Dec 19  Al mono  17.8 W  100.0 µ  45.0°  23.50 eV 9.8405e+002 max 4.97 min
C1s/Area2: P4/1
282284286288290292
0
200
400
600
800
1000
12121909.spe
Binding Energy (eV)
c/
s
Atomic % 
N 1s 6.87% 
O 1 s 32.12% 
C 1s 59.71% 
Atomic % 
N 1s 0.14% 
O 1 s 43.53% 
C 1s 56.33% 
Atomic % 
N 1s - 
O 1 s 45.45% 
C 1s 54.55% 
O/C 
ratio 
0.83 O/C 
ratio 
0.77 O/C 
ratio 
0.54 
(C6H10O5)n 
a b c Non-purified BNC Day 14 Day 28 
Co
u
n
ts
 
Binding Energy (eV) Binding Energy (eV) Binding Energy (eV) 
  
 
33 
 
 
Figure 9 – Bacterial endotoxin testing of BNC during the first depyrogenation process of large BNC cylinders in 
perfusion system and after the second depyrogenation process in endotoxin-free water. (Paper II) 
 
 
Figure 10 – X-ray diffraction pattern of densified BNC hydrogels after second purification process. The detected 
diffraction peaks at 2θ = 14.7°, 16.2° and 22.4°, characteristic peaks of cellulose I; and the absence of the peaks at 
2θ = 12.1° and 20.8°, characteristic peaks of cellulose II, gives substantial evidence that the perfusion of BNC with 
0.5M NaOH for a period of 28 days did not change the crystalline structure of BNC fibrils from cellulose I to 
cellulose II. (Paper II) 
The crystallinity of the densified BNC hydrogel after the purification process was investigated 
with XRD. The XRD pattern shows three major diffraction peaks located at 2θ = 14.4°, 16.7°, 
and 22.6° (Figure 10). These peaks correspond to the primary diffraction of the (110), (110), and 
(200) planes of polymorph cellulose I.154,155 No peaks were observed at 2θ = 12.1° and 20.8°, 
which are characteristic peaks of cellulose II.156 This demonstrates that the purification process 
did not induce any crystalline structure changes in the BNC fibrils from cellulose I to cellulose II. 
Moreover, the relative crystallinity determined from the XRD data was 89 % (Figure 10). Gea et 
al.91 reported a washing treatment for BNC with 2.5 wt% NaOH (0.625 M) followed by 2.5 wt% 
NaOCl, which also did not induce the transformation from cellulose I to II. Although the 
treatment with NaOH was much shorter in this previous study, the XRD patterns of the NaOH-
treated BNC are very similar to our results. 
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Extracts of the non-pyrogenic densified BNC hydrogel disks were tested for in vitro cytotoxicity. 
The cultivation of sensitized L929 cells in BNC extracts revealed no cytotoxic effects, 
demonstrated by the high cell viability (108.4 ± 7.5 %). A cell viability between 70 and 100 % 
shows that there were no cytotoxic components in the extracts. As expected, the viability of L929 
cells significantly decreased when incubated in 10 % DMSO (13.3 ± 1.5 %), which was used as 
positive control (Figure 11). Cell viability below 50 % reflects strong cytotoxic effects. Thus, 
biocompatibility testing according to standards set forth in ISO 10993-5 demonstrated that 
densified BNC hydrogel is non-cytotoxic after the purification process. 
 
 
Figure 11 – In vitro cytotoxicity testing of densified BNC hydrogels after second depyrogenation process in 
endotoxin-free water. Biocompatibility testing according to standards set forth in ISO 10993-5 demonstrated that 
densified BNC hydrogel is non-cytotoxic after the purification process. (Paper II) 
5.2.2 In vivo biocompatibility evaluation 
The macroscopic assessment over the implantation period revealed no signs of inflammation 
around the implants.  Furthermore, all implants showed an intimate integration with the 
surrounding soft tissue after 1-week intradermal implantation. Histological analysis was 
performed to evaluate the biocompatibility index of the three different materials. The score for 
neutrophil PMNCs and macrophages revealed a slightly higher occurrence of both cell types in 
the densified BNC hydrogel implants compared to autologous cartilage, but no significant 
differences were observed (Figure 12a–b). A moderate level of PMNCs and macrophages was 
detected in Gore-Tex implants, where a significant difference was observed compared to 
autologous auricular cartilage (p<0.05). A total absence of lymphocytes and plasma cells was 
noted in all implanted groups (Figure 12c–d). There was a slight infiltration of giant cells in the 
Gore-Tex implants, whereas in densified BNC hydrogel and autologous cartilage implants, none 
to slight infiltration could be observed (Figure 12e). A significant difference (p<0.05) in giant 
cell-infiltration was observed between Gore-Tex and densified BNC hydrogel implants (median 
scores: 1 and 0, respectively).  
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Figure 12 – Classification scores for evaluation of inflammatory reaction of autologous cartilage, densified BNC 
hydrogel (dBNC) and medical grade Gore-Tex after 1-week intradermal implantation. Median score indicated by 
line. Classification scores: 0 absent, 1 slight, 2 moderate, 3 marked, 4 severe (*p< 0.05). (Paper II) 
 
 
Figure 13 – Classification scores for evaluation of fibrotic reaction of autologous cartilage, densified BNC hydrogel 
(dBNC) and medical grade Gore-Tex after 1-week intradermal implantation. Median score for each implant group 
indicated by line. Classification scores: 0 absent, 1 slight, 2 moderate, 3 marked, 4 severe (*p< 0.05). (Paper II) 
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Regarding the level of necrosis, significant differences (p<0.05) were observed in densified 
BNC implants compared to Gore-Tex and autologous cartilage implants. In autologous cartilage 
and Gore-Tex implants, no signs of necrosis were found. However, slight to moderate necrosis 
was observed in densified BNC hydrogel implants (Figure 13a). For all experimental groups, 
slight levels of fibrosis as well as encapsulation were detected. However, no significant 
differences were detected between the groups (Figure 13b–c). A slight level of 
neovascularization was detected in Gore-Tex implants, but none was detected in the other 
experimental groups. Moreover, none of the three materials demonstrated any signs of 
degradation (Figure 13d–e). 
 
The biocompatibility testing revealed a significantly lower inflammatory reaction caused by the 
autologous cartilage (1.0 ± 1.0) implants compared to densified BNC hydrogel (6.0 ± 2.0) or 
Gore-Tex implants (10.0 ± 4.0) (Figure 14a). Regarding the fibrotic reaction, densified BNC 
hydrogel implants (1.5 ± 0.5) induced a lower reaction than autologous cartilage (2.0 ± 1.0) and 
Gore-Tex (2.0 ± 1.0), but no significant differences were detected (Figure 14b). On the basis of 
tissue and cellular responses, the biocompatibility index of the autologous cartilage group (3.5 ± 
2.0) was significantly lower than the densified BNC hydrogel (7.5 ± 1.5) and Gore-Tex (12.0 ± 
3.0) implant groups. Based on the recommendations of ISO 10993-6 Appendix E, autologous 
cartilage and BNC implant groups were considered a slight irritant to the host tissue, whereas the 
Gore-Tex group was considered a moderate irritant to the host tissue (Figure 14c-f). 
 
Figure 14 – In vivo biocompatibility evaluation: (a) inflammatory reaction, (b) fibrotic reaction and (c) 
biocompatibility index of autologous cartilage, densified BNC hydrogel (dBNC) and medical grade Gore-Tex after 
1-week intradermal implantation. Representative hematoxylin and eosin-stained cross-sections of (d) autologous 
cartilage, (e) densified BNC hydrogel and (f) Gore-Tex explants (shown by arrows). Scale bar 500 µm. The 
biocompatibility index of the autologous cartilage group (3.5 ± 2.0) was significantly lower than the densified BNC 
hydrogel (7.5 ± 1.5) and Gore-Tex (12.0 ± 3.0) implant groups. Autologous cartilage and BNC implant groups were 
considered a slight irritant to the host tissue, whereas the Gore-Tex group was considered a moderate irritant to the 
host tissue. (*p< 0.05) (Paper II) 
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The extent of the acute inflammatory response depends on the injury. In this context, it depends 
on the reactions caused by the material properties. The implantation of a biomaterial initially 
evokes tissue and cellular host responses to the locally applied defect and includes not only 
inflammatory reactions but also wound healing and foreign body responses.157,158 The scores for 
the inflammatory and fibrotic reactions take into account different cell types and tissue reactions 
involved in the acute inflammatory response and wound healing response. During inflammation, 
a complex multistage process involving numerous cell types, slight infiltration of neutrophil 
PMNCs and macrophages was observed in densified BNC hydrogel and Gore-Tex implants. 
Neutrophil PMNCs are rapidly recruited into the implantation site and characterized as cells of 
the short-lived (hours to days) acute inflammatory reactions induced by the implanted foreign 
material.157,159,160 In the normal wound healing sequence, the chronic inflammation follows the 
phase of acute inflammation and is also of short duration (days). It is characterized by 
macrophages as dominant cellular infiltrate in implanted biomaterials.157,160,161 
 
The rare presence of neutrophil PMNCs and macrophages in the autologous cartilage implants 
after 1-week intradermal implantation indicated a non-irritating effect on the surrounding tissue, 
whereas a significant increase of these cell types in the Gore-Tex implants revealed a persistent 
acute inflammatory phase (Figure 12a, b). On the basis of the detected significant differences in 
neutrophil PMNCs and macrophage infiltration between autologous cartilage and Gore-Tex 
implants, we hypothesize that the acute inflammation is not only caused by the implantation 
procedure but is also elicited by the implanted material itself (i.e. Gore-Tex). The slight presence 
of these two cell types in the densified BNC hydrogel implants suggests a slight foreign body 
reaction compared to Gore-Tex, which is advantageous for densified BNC hydrogel as a 
biomaterial.  
 
As lymphocytes and plasma cells are known to be involved in immune reactions and in the 
chronic inflammatory phase,157 their complete absence in our experiments may be explained by 
the short-term implantation period (Figure 12c, d). The assessment of tissue responses after 
short-term implantation may not fully reflect the biological response to the implanted material but 
can indicate the extent and progression to a chronic inflammation. As formation of granulation 
tissue is initiated within 1 day after implantation,159,162 the short-term implantation period applied 
in our study is temporally sufficient for the detection of granulation tissue and foreign body 
reaction.  
 
In the granulation tissue response, the principle task of macrophages is to clear the implant site of 
tissue and cellular debris (phagocytosis), and participate in the foreign body reaction at the 
implant–tissue interface.157 Additionally, in sequence of normal host response to implants, 
macrophages coalesce to form multinucleated foreign body giant cells. Giant cells are tightly 
associated with the foreign body response and typically can be detected on the surface of the 
implanted materials,161,162 as we could demonstrate for Gore-Tex implants. In contrast, no giant 
cells were observed on the surface of autologous cartilage and densified BNC hydrogel implants 
(Figure 12e). In line with this process, macrophages initiate tissue remodeling; accumulation of 
fibroblasts, inducing the formation of the fibrous capsule; and neovascularization by secreting 
various biologically active products.157,159,161,162 Based on experienced data known from 
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literature, we can conclude that the significant increase of giant cells as well as the slight levels 
of neovascularization and encapsulation (Figs. 6e and 7c, d) observed in Gore-Tex implants 
indicate a more distinct granulation tissue formation and foreign body reaction compared to the 
autologous cartilage and densified BNC hydrogel implants. 
 
In support with our previous findings (Paper I), we conclude that densified BNC hydrogel with 
cellulose content of 17 % is a promising non-degradable biomaterial for auricular cartilage tissue 
engineering, due to its similarity with auricular cartilage in terms of mechanical strength and host 
tissue response. 
 
5.3 Macroporous BNC-A composite scaffolds for auricular cartilage regeneration 
 
When densified, BNC is a mechanically and biologically appropriate biomaterial for use in 
auricular cartilage reconstruction (Paper I and II). However, its dense nanocellulose network 
prevents cells from penetrating the material. To circumvent this problem, several techniques have 
been developed to support cell ingrowth in BNC scaffolds by tuning pore size and pore 
interconnectivity during biosynthesis of BNC,149 via laser ablation75 and freeze-dry processing.85 
In this study macroporous BNC-Alginate (BNC-A) composite scaffolds were fabricated by a 
freeze-drying process, and scaffolds with two different compositions were produced. 
Subsequently, we investigated cell ingrowth and redifferentiation capacity of hNCs seeded in 
macroporous BNC-A composite scaffolds in vitro, where the effect of scaffold composition on 
neocartilage formation was evaluated. 
 
Two groups of BNC-A composite scaffolds, 50/50 and 90/10, were evaluated. As seen from SEM 
images, similar macroporous morphology with high degree of interconnectivity was observed in 
both types of BNC-A composite scaffolds (Figure 15a and c). Furthermore, the microstructure of 
the scaffolds was affected by the alginate concentration. That is, a low alginate content (i.e. 
90/10) yielded a surface topography with nanofibrous structure, whereas a higher alginate content 
(i.e. 50/50) yielded scaffolds with a noticeably smoother surface topography (Figure 15b and d). 
Extracts of both BNC-A composite scaffolds were tested for endotoxin content and in vitro 
cytotoxicity. The LAL test detected an endotoxin content of <1.0 EU/ml in both scaffold types. 
This result is expected since the BNC pellicles were not purified in sterile and non-pyrogenic 
conditions. The cultivation of sensitized L929 cells and hNCs in these extracts revealed no 
cytotoxic effects, as demonstrated by the high cell viabilities (Figure 16a, b). As cell viabilities 
between 80% and 100% were observed, the cytotoxic potential of both BNC-A composite 
scaffolds was classified as non-cytotoxic (cell viability > 71%). 
 
A significant increase in cell number was observed in 50/50 and 90/10 BNC-A composite 
scaffolds after 42 days (1.09 ± 0.11 × 106 and 1.04 ± 0.05 × 106 cells/scaffold, respectively) of 3D 
culture compared to day 1 (21.9 ± 2.1 × 103 and 27.7 ± 2.9 × 103 cells/scaffold, respectively). No 
differences were detected between the two BNC-A scaffold groups (Figure 17a). Furthermore, 
GAG content was significantly higher in the 50/50 BNC-A group (66.24 ± 18.29 µg/mg) 
compared to the 90/10 BNC-A group (38.64 ± 11.67 µg/mg) after 42 days of culture. A 
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significantly higher GAG content was found in both scaffold types after 42 days compared to 
14 and 28 days of 3D culture (Figure 17b). 
 
 
Figure 15 – SEM analyses of macroporous BNC-Alginate composite scaffolds (a, b) 50/50 and (c, d) 90/10 indicate 
a highly open porous structure in both composite scaffolds. (d) The BNC-A composite scaffolds with lower alginate 
content (90/10) preserved the nano-structured surface topography of pure BNC, whereby the BNC fibers are clearly 
visible. The scale bars indicate (a, c) 500 µm and (b, d) 5 µm. 
 
Figure 16 – In vitro cytotoxicity testing of BNC-Alginate composite scaffolds 50/50 and 90/10 (n=12 each). (a) L929 
and (b) human nasoseptal chondrocytes (hNCs) were used as indicator cells to determine possible cytotoxic effects 
caused by the scaffold materials and production process. Both cell types show a high viability, indicating the non-
cytotoxicity of the BNC-A composite scaffolds. 
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Figure 17 – (a) Proliferation of chondrocytes and (b) GAG content in 50/50 (black) and 90/10 (grey) BNC-A 
composite scaffolds (n = 6 per time point). During 3D culture cell proliferation and accumulation of GAGs were 
observed. No differences in cellularity were found between the two scaffold compositions, whereas GAG content was 
higher in 50/50 scaffolds. Error bars represent the standard deviation of the mean. *p< 0.05. 
 
Figure 18 – Gene expression analyses of chondrogenic markers (a) ACAN, (b) COL2A1, and dedifferentiation 
markers (c) VCAN and (d) COL1A1 expressed in hNCs cultured in 50/50 (black) and 90/10 (grey) BNC-A composite 
scaffolds (n = 6 per time point). Gene expression was normalized to human nasoseptal cartilage (dashed line). The 
expression of evaluated marker genes was higher for hNCs cultured in 50/50 compared to 90/10 BNC-A composite 
scaffolds. Error bars represent the standard deviation of the mean. *p< 0.05. 
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Higher gene expression levels of chondrogenic markers ACAN and COL2A1 were found in the 
50/50 BNC-A group (Figure 18a, b). ACAN expression increased significantly between 14 days 
(0.62 ± 0.34-fold) and 42 days (1.93 ± 0.47-fold) of 3D culture in 50/50 BNC-A scaffolds and 
was significantly higher compared to the 90/10 BNC-A group after 42 days of culture (0.40 ± 
0.13-fold). The expression of COL2A1 was maintained at higher levels in the 50/50 BNC-A 
group after 14 (1.99 ± 0.73-fold) and 28 (1.81 ± 0.73-fold) days of culture, but then decreased 
after 42 days (0.46 ± 0.17-fold). Similarly, after 14 days COL1A1 expression was significantly 
higher in the 50/50 BNC-A group (7.22 ± 3.10-fold) compared to the 90/10 BNC-A group (2.11 
± 0.81-fold), but it decreased significantly for both scaffold types after 42 days of culture (0.67 ± 
0.21-fold and 0.44 ± 0.06-fold, respectively). Furthermore, lower expression levels of VCAN 
were found in hNCs cultured in both scaffold types compared to native cartilage (Figure 18c, d). 
 
 
Figure 19 – Histological Alcian blue staining and immunohistochemical staining specific for the detection of 
aggrecan, type II collagen and type I collagen in chondrocyte-seeded (a-h) 50/50 and (i-p) 90/10 BNC-A composite 
scaffolds after 14 and 42 days in chondrogenic culture conditions. Positive immunostains for aggrecan and collagen 
type II were detected in both types of BNC-A composite scaffolds. 
Chondrogenic matrix deposition was further confirmed by histological and immunohistological 
analyses. In 50/50 BNC-A composite scaffolds, only slight positive stains for GAGs, aggrecan 
and collagen type I and II were observed after 14 days of culture (Figure 19 a–d). On the other 
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hand, neocartilage accumulation in the form of aggrecan and collagen type II was found in the 
marginal areas of 90/10 BNC-A composite scaffolds after 14 days of culture. Although the 
central part of the scaffolds showed good cell infiltration, not much neocartilage was found in 
this area. A slight positive staining for GAGs and collagen type I was also detected in 90/10 
BNC-A scaffolds (Figure 19 i–l). After long-term 3D culture, neocartilage depositions (GAGs, 
aggrecan and collagen type II) were found notably in both BNC-A composite scaffolds, 
predominantly at the marginal areas of the scaffolds (Figure 19 e–g, m–o). 
 
Native BNC is known to be impenetrable to cells or at best the migration is limited to the 
surface.32,76,163,164 Thus, different fabrication methods to create macroporous BNC scaffolds that 
support cell infiltration have been investigated previously.75,85,149 As observed from our results, 
both macroporous BNC-A composite scaffolds provide an adequate environment that supports 
ingrowth, proliferation and redifferentiation of hNCs; in agreement with previous studies that 
have evaluated porous BNC scaffolds with human chondrocytes.75,83,165 After 42 days of 3D 
culture, depositions of cartilage-specific ECM such as GAGs, aggrecan and collagen type II were 
found notably in both BNC-A composite scaffolds. Moreover, macroporous BNC-A composite 
scaffolds with higher alginate content (i.e. 50/50) positively influenced the chondrogenic 
phenotype, as demonstrated by the higher gene expression levels of chondrogenic markers ACAN 
and COL2A1. However, the gene expression of the dedifferentiation markers VCAN and COL1A1 
was also higher in the hNCs seeded in this scaffold type. Although there was a higher expression 
of the evaluated chondrogenic markers in the 50/50 BNC-A scaffold, other aspects were also 
considered, i.e. sterilization capability, to select a scaffold composition for further studies. The 
50/50 BNC-A scaffold could not be sterilized using an effective and reliable method, such as 
steam sterilization, due to the high alginate content. On the other hand, the 90/10 BNC-A 
composite scaffold could be sterilized by autoclaving without damaging the macroporous 
structure. HNCs seeded in 90/10 BNC-A scaffolds were shown to infiltrate the scaffold. 
Furthermore, the cells proliferate and produce neocartilage in such scaffold. Therefore, we 
concluded that the 90/10 BNC-A composite scaffold is suitable for auricular cartilage TE. 
 
5.4 Bilayer bacterial nanocellulose scaffold for auricular cartilage regeneration 
 
In Paper III166 a novel BNC scaffold designed with a bilayer architecture that integrates 
mechanical stability and high porosity was evaluated for auricular cartilage TE, in vitro and in 
vivo. Bilayer BNC scaffolds with a dense and porous layer were successfully fabricated. SEM 
images revealed a compact BNC network structure in the dense layer and a macroporous 
structure in the porous layer (Figure 20). The dense and porous layers were stable and firmly 
attached, which facilitated the handling of the scaffolds during the purification process and 
throughout the study. 3D morphometric analysis showed that bilayer BNC scaffolds have a 
porosity of 75% and mean pore size of 50 ± 25 µm (Figure 20f, g). 
 
The ionic liquid EMIMAc offers a novel cellulose solvent system to achieve a strong interfacial 
molecular bonding between the cellulosic dense and porous layers. We are not aware of any other 
methods that can achieve such result. On the other hand, using EMIMAc increases the risk of 
having cytotoxic compounds in the bilayer BNC scaffolds, if these residues are not properly 
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removed during the purification process. Since the toxicity of ionic liquids is not well 
understood, the use of EMIMAc to fabricate the bilayer BNC scaffolds was investigated with 
precaution. The cytotoxicity of imidazole ionic liquids has been studied in a human lung 
carcinoma epithelial cell line model, and it was found that the alkyl-chain length of the ionic 
liquid has an influence on cytotoxicity.167 However, the cytotoxicity of EMIMAc, in particular, 
has not been studied in eukaryotes. Consequently, we analyzed the removal of EMIMAc from the 
bilayer BNC scaffolds with ATR-FTIR spectroscopy, followed by in vitro cytotoxicity testing 
with sensitized L929 cells. The strong peak at wavenumber 1566 cm-1 was used to detect 
EMIMAc residues in the ATR spectra of bilayer BNC scaffolds, as it has been shown that this 
peak is composed of two overlapped peaks that correspond to the carboxyl group of the acetate 
and an underlying ring mode of the cation.122,123 Since the peak at 1566 cm-1 was found in the 
ATR spectra of bilayer BNC scaffolds that had been washed for 1 and 7 days, it was considered 
necessary to continue washing the scaffolds in endotoxin-free water. The washing process proved 
to be successful in removing the EMIMAc residues, as first observed in the ATR spectra of 
samples that were washed for 14 days. The absence of this peak confirmed the removal of 
EMIMAc residues from the BNC bilayer scaffolds (Figure 21a). 
 
 
Figure 20 – (a) Photograph of bilayer BNC scaffold (side view). Comparison between (b, c) scanning electron 
microscopy images of bilayer BNC scaffolds and (d) 3D reconstructed model of the porous layer using 
microtomography. Similar honeycomb arrangement of sheet-like structures is visible in both images. (e) Higher 
magnification of the area marked red in (d). Morphometric analysis of segmented porous layer: (f) Morphometric 
parameters (Sc.Po: scaffold porosity, Pore.Th: volume-weighted mean pore size, Wall.Th: scaffold wall thickness, 
and Wall.N: scaffold wall number) and (g) Histogram of pore size distribution. (Paper III) 
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Figure 21 – (a) ATR spectra of (1) 1-Ethyl-3-methylimidazolium acetate (EMIMAc); bilayer BNC scaffolds after (2) 
1 day, (3) 7 days and (4) 14 days of purification in endotoxin-free water; and (5) pure bacterial nanocellulose 
(BNC). (b) In vitro cytotoxicity testing of bilayer BNC scaffolds after 7 and 14 days of purification in endotoxin-free 
water (n=4 per time point). Post hoc comparisons using the Tukey HSD test indicated that the mean cell viability for 
the 14-day condition (97.8 ± 4.7%) was significantly higher than the 7-day (18.4 ± 3.6%) and positive control 
conditions (25.6 ± 5.5%) at the *p<0.05 level. Furthermore, there was no significant difference between the negative 
control and 14-day conditions. Thus, the cytotoxic potential of bilayer BNC scaffolds was classified as non-cytotoxic. 
Error bars represent the standard deviation of the mean. (Paper III) 
In vitro cytotoxicity testing supported our findings from ATR-FTIR. Bilayer BNC scaffolds 
washed for 7 days still had residues of EMIMAc that were highly cytotoxic to L929 cells (cell 
viability: 18.4 ± 3.6%). However, these residues were further reduced after the purification 
process with endotoxin-free water; yielding non-cytotoxic bilayer BNC scaffolds (cell viability: 
97.8 ± 4.7%; Figure 21b). These results are in good agreement with our previous study, which 
evaluated the cytotoxic potential of pure densified BNC hydrogel disks (i.e. dense BNC layer, 
Paper II153) and found the material to be non-cytotoxic. All together, the results from ATR-FTIR 
and in vitro cytotoxicity testing demonstrated that EMIMAc residues were successfully removed 
from the bilayer BNC scaffolds after the purification process with endotoxin-free water; whereat 
no peak at 1566 cm-1 and no cytotoxic effects were observed. Furthermore, endotoxin analysis 
revealed that the produced bilayer BNC scaffolds were non-pyrogenic (0.15 ± 0.09 EU/ml) after 
the purification process. The endotoxin content found in the scaffolds is three times lower than 
the endotoxin limit (0.5 EU/ml) set by the FDA for medical devices.90 This low endotoxin 
content found in the bilayer BNC scaffolds is in good agreement with our previous results (0.10 
EU/ml, Paper II153), where densified BNC hydrogel disks (i.e. dense layer) of similar dimensions 
were considered non-pyrogenic after purification with endotoxin-free water for 14 days. 
 
Gross examination of the hNC-seeded constructs throughout the 6 weeks of in vitro culture 
revealed a stable adhesion between the dense and porous layers. Moreover, the size and shape of 
the bilayer BNC scaffolds remained stable during the cell culture. The compact BNC network 
structure of the dense layer provided a good mechanical stability, while the interconnected high 
porosity layer supported the ingrowth of hNCs throughout this layer. As demonstrated in Alcian 
blue-stained images, the porous layer supported the ingrowth of hNCs and facilitated a 
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homogeneous cell distribution  (Figure 22a). However, it took 4 weeks of in vitro culture to get 
a dense and homogenous cell distribution. After 6 weeks of in vitro culture, a rich and 
homogenous distribution of hNCs and neocartilage was observed throughout the porous layer of 
the scaffold, even in the center, which is known to be a critical region in static 3D culture due to 
the limited supply of nutrients and oxygen. This outcome could have been accelerated by 
increasing the percentage of cells retained in the scaffolds after cell seeding, as there was a 
substantial loss of cells when these were seeded in medium. Thus, for the in vivo study the cells 
were embedded in alginate to improve cell retention in the scaffolds after seeding. Alginate was 
chosen, since it has been successfully used to seed chondrocytes in a scaffold for in vivo 
implantation168,169 and this hydrogel is well known to maintain a chondrogenic phenotype of 
human chondrocytes and stimulate neocartilage formation.170 
 
Deposition of ECM by the hNCs seeded in bilayer BNC scaffolds was assessed qualitatively by 
immunohistological staining. During 3D culture, hNCs produced and accumulated cartilage-
specific ECM components in the bilayer BNC scaffolds. A positive staining for s-GAGs was 
found around clusters of chondrocytes in the porous layer after 2 weeks of culture, as shown by 
the Alcian blue staining (Figure 22a). Moreover, synthesis and accumulation of s-GAGs, 
aggrecan as well as type II collagen increased visibly during 3D culture (Figure 22a-c). After 6 
weeks of in vitro culture, a rich and homogenous distribution of cells and neocartilage was 
observed throughout the porous layer of the scaffold, even in the center, which is known to be a 
critical region in static 3D culture due to the limited supply of nutrients and oxygen. However, 
fibrocartilage ECM was also synthesized by the hNCs in the bilayer BNC scaffolds, as 
demonstrated by the positive immunostaining of type I collagen (Figure 22d). 
 
The chondrogenic potential of the hNCs in the bilayer BNC scaffolds was also investigated on 
the basis of the expression of the chondrogenic marker genes ACAN and COL2A1. 
Dedifferentiation markers, VCAN and COL1A1, were also analyzed. Gene expression analyses 
confirmed the positive immunostains of aggrecan, type II and type I collagen. ACAN and 
COL2A1 expression after 6 weeks was 3.4- and 4.9-fold higher, respectively, compared to gene 
expression levels at week 2. Expression of COL1A1 was also upregulated during 3D culture, 
where after 6 weeks was 1.7-fold higher compared to gene expression levels at week 2. On the 
other hand, expression of VCAN remained relatively close to zero during the 6 weeks of 3D 
culture (Figure 22e, f). The upregulation of the chondrogenic markers ACAN and COL2A1 was 
clearly enhanced compared to the expression of dedifferentiation markers, revealing the 
chondrogenic potential of the hNCs in the bilayer BNC scaffolds. 
 
The stability and neocartilage formation in MNC/hNC-seeded and cell-free bilayer BNC 
scaffolds were evaluated after 8 weeks of subcutaneous implantation in nude mice. The mice 
survived until the end of the study period, during which no extrusion of constructs was observed. 
At 8 weeks post-implantation, a thin fibrous capsule surrounded all MNC/hNC-seeded and cell-
free bilayer BNC scaffolds; considered a normal non-pathological foreign body reaction. 
Macroscopic examination of the explants revealed that the shape and size of the bilayer BNC 
scaffolds remained stable and no delamination of the dense and porous layers was observed in 
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any of the constructs. Furthermore, bilayer BNC scaffolds seeded with MNCs and hNCs 
encapsulated in alginate had a macroscopically cartilage-like appearance (Figure 23a). 
 
 
Figure 22 – Histological and immunohistochemical analysis of human nasoseptal chondrocytes (hNC) after 2, 4 and 
6 weeks of culture in vitro in chondrogenic medium. Representative images of ECM produced in bilayer bacterial 
nanocellulose (BNC) scaffolds. Samples were stained with (a) Alcian blue to detect deposition of sulfated 
glycosaminoglycans (PL =porous layer). Immunohistochemical staining was used to detect cartilage-specific 
proteins such as (b) aggrecan, (c) type II collagen and (d) the dedifferentiation marker type I collagen. (e and f) 
Gene expression analysis of hNCs seeded in bilayer BNC scaffolds and cultured in vitro for 2, 4 and 6 weeks (n=4 
per time point). Gene expression levels of ACAN, COL2A1, COL1A1 and VCAN relative to the housekeeping gene 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Error bars represent the standard deviation of the mean. 
The scale bar indicates 1 mm (a-d). (Paper III) 
These MNC/hNC-seeded constructs were stiffer and more stable upon handling, compared to 
bilayer BNC scaffolds seeded with cell-free alginate solution. Based on gross morphological 
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examination, there were no signs of adhesive failure in the bilayer BNC scaffolds after the in 
vitro and in vivo studies. We postulate that the interfacial bonding between the layers is like a 
molecular welding process. As the BNC-EMIMAc solution partly dissolves both surfaces at the 
interface, this makes it possible for the long chains of BNC to diffuse into both layers. Once the 
dissolved BNC is precipitated in ethanol, the interface structure is locked, which results in a 
stable interfacial bonding. We have observed that when pulling the dense and porous layers apart, 
the scaffold breaks at the porous layer, similar to a structural failure. In contrast, a weak adhesion 
would have had resulted in an adhesive or cohesive failure at the interface. Based on this 
observation we speculate that the interfacial bonding between the layers is stronger than the 
structure of the porous layer, although in this study the interfacial strength of the bilayer BNC 
scaffolds was not measured. 
 
In the in vivo study we explored the application of a clinically relevant strategy, by seeding 
bilayer BNC scaffolds with a low number of freshly isolated hNCs combined with freshly 
isolated human MNCs, in order to test the translation of this auricular cartilage TE technology to 
the clinic. At 8 weeks post-implantation, the cells encapsulated in alginate were homogeneously 
distributed in the porous layer of the scaffolds (Figure 23b, c). Moreover, deposition of cartilage 
matrix components such as proteoglycan and type II collagen were observed predominantly in 
MNC/hNC-seeded constructs. The strong Safranin O staining surrounding the cells showed the 
presence of proteoglycans in the newly synthesized ECM, while the presence of type II collagen 
was confirmed by immunohistochemistry (Figure 23b, c). These results, showing the formation 
of neocartilage in the porous layer, were further confirmed by biochemical analysis. A 
Kolmogorov-Smirnov test indicated a significant difference (p<0.05) between mean GAG 
content for MNC/hNC-seeded (0.87 ± 0.65 µg GAG/mg wet weight) and cell-free bilayer BNC 
scaffolds (0.07 ± 0.11 µg GAG/mg wet weight). GAG-production in the MNC/hNC group was 
almost 12-fold higher compared to the control condition (Figure 23d). 
 
A typical stress relaxation behavior was observed in all bilayer BNC scaffolds (MNC/hNC-
seeded and cell-free controls), and the following measurements were determined for the 
MNC/hNC-seeded constructs at 8 weeks post-implantation; 0.76 ± 0.19 MPa for Ein, 0.19 ± 0.08 
MPa for Eeq, 0.16 ± 0.07 MPa for σmax and 7.1 ± 3.4 seconds for t1/2. A one-way ANOVA was 
conducted to compare the effect of implantation and seeding of MNC/hNCs on initial matrix 
stiffness (i.e. Ein) of the constructs at 8 weeks post-implantation. There was a significant effect of 
implantation and seeding of MNC/hNCs on instantaneous modulus for the three conditions, F(2, 
23) = 16.10, p<0.0001, ω = 0.73. Post hoc comparisons using the Tukey HSD test indicated that 
the mean Ein for the MNC/hNC condition (0.76 ± 0.19 MPa) was significantly higher than the 
non-implanted (0.42 ± 0.15 MPa) and cell-free conditions (0.32 ± 0.10 MPa) at the p<0.05 level. 
The cell-free implanted condition did not significantly differ from the non-implanted condition 
(Figure 23e). 
 
Moreover, a Kruskal–Wallis test was conducted to compare the effect of implantation and 
seeding of MNC/hNCs on relaxation kinetics (i.e. t1/2) and intrinsic properties (i.e. Eeq and σmax) 
of the constructs at 8 weeks post-implantation. The median t1/2 values of the constructs were 
significantly affected by the implantation and seeding of MNC/hNCs, H(2) = 17.46, p<0.001. 
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Figure 23 – (a) Photographs of cell-free and MNC/hNC-seeded bilayer BNC scaffolds after 8 weeks of subcutaneous 
implantation in nude mice. Histological evaluation of ECM in bilayer bacterial nanocellulose (BNC) scaffolds 
seeded with a combination of freshly isolated human nasoseptal chondrocytes (hNC) and bone marrow mononuclear 
cells (MNC) in alginate after 8 weeks of subcutaneous implantation. (b) Safranin O stain was used to examine 
proteoglycans present in the newly synthesized ECM, (c) whereas immunohistochemical analysis was used to detect 
type II collagen. (d) Cell-free and MNC/hNC-seeded bilayer BNC scaffolds were also analyzed for 
glycosaminoglycan (GAG) content after 8 weeks of subcutaneous implantation (n=4 per group). (e) Biomechanical 
evaluation of cell-free and MNC/hNC-seeded constructs after 8 weeks of subcutaneous implantation (n=4 per 
group), and non-implanted bilayer BNC scaffolds with cell-free alginate solution (n=5). Error bars represent the 
standard deviation of the mean. *, ** or *** indicates p-values less than 0.05, 0.01 or 0.001, respectively. The scale 
bars indicate 4 mm (a) and 1 mm (b, c). (Paper III) 
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However, Eeq and σmax were not significantly affected by the tested conditions, H(2) = 4.19, p = 
0.12 and H(2) = 1.12, p = 0.57, respectively. Post hoc comparisons using the Mann–Whitney 
tests indicated that the median t1/2 for the MNC/hNC condition was significantly higher than the 
non-implanted (U = 3, p<0.001, r = -0.74) and cell-free conditions (U = 48, p<0.01, r = -0.66). 
No significant differences in t1/2 were detected between the cell-free and non-implanted 
conditions. A 2.4- and 3.4-fold higher Ein and t1/2, respectively, were observed in the MNC/hNC-
seeded constructs compared to the cell-free group. Likewise, a 1.8- and 3.6-fold higher Ein and 
t1/2, respectively, was observed in the MNC/hNC-seeded constructs compared to the non-
implanted group (Figure 23e). 
 
The presence of cartilage matrix in the bilayer BNC scaffolds was also supported by 
biomechanical analysis. At 8 weeks post-implantation, a significantly higher initial matrix 
stiffness and improved relaxation kinetics (i.e. higher Ein and t1/2 values) were observed in the 
MNC/hNC-seeded scaffolds compared to the non-implanted and cell-free conditions. In fact, the 
effect size (i.e. ω and r > 0.5) obtained from the Ein and t1/2 data represents a large effect by the 
MNC/hNC condition. However, there was no significant difference in Eeq and σmax for the three 
conditions. Considering the improved relaxation kinetics in the MNC/hNC-seeded constructs, we 
conclude that the ability of the constructs to attract and trap water was enhanced through the 
production and accumulation of proteoglycans and glycosaminoglycans in the bilayer BNC 
scaffolds. Nevertheless, since the intrinsic scaffold properties did not improve in the MNC/hNC-
seeded constructs compared to the cell-free control (no difference in Eeq), it implies that collagen 
matrix was not effectively produced in the porous layer. To put the results from the 
biomechanical analysis in a clinical context, the Ein and Eeq of the MNC/hNC-seeded constructs 
after 8 weeks of implantation were 8.4- and 17.4-fold lower, respectively, compared to human 
auricular cartilage (6.4 ± 3.2 MPa for Ein and 3.3 ± 1.3 MPa for Eeq; Paper I143) Therefore, the 
engineered cartilage as such would not be suitable for immediate ear cartilage replacement; rather 
modifications in cell concentration and perhaps a longer implantation period needs to be 
considered. 
 
The present study has certain limitations. Firstly, cell density plays a critical role when 
engineering functional and stable cartilage. Others have demonstrated that cell densities greater 
than 20 × 106 cells/ml are desirable, while low cell densities resulted in decreased cartilage 
formation.171 In order to enhance the outcome of tissue-engineered auricular cartilage, a higher 
cell density is needed to benefit from increased cell–cell contacts signaling chondrogenic ECM 
deposition and preventing the dedifferentiation process. Despite the limitations already stated, our 
findings support that bilayer BNC scaffolds in combination with alginate provide a suitable 
environment for MNCs and hNCs to support the synthesis of neocartilage. Of equal importance, 
the use of freshly isolated hNCs and MNCs in the in vivo study gave us an indication of the 
potential of this strategy to advance the translation of cell-aided treatments to the clinic. 
 
Most auricular cartilage TE strategies have revolved around biodegradable scaffolds, where the 
hypothetical optimum has been the scaffold's degradation orchestrated by the neo-tissue 
formation. It would be ideal if the scaffold could be degraded by the time the neocartilage has 
reached full mechanical strength. However, fine-tuning this intricate play has proven to be a 
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challenge in TE. If the material degrades too rapidly, the neocartilage will collapse. Whereas if 
it degrades too late, it could induce a continuous inflammation that would affect the cartilage 
formation. Thus, we aim for a hybrid implant—BNC well integrated with the host and neo-
tissue—that supports cell ingrowth, neocartilage formation and long-term structural integrity after 
implantation. The non-degradable BNC will provide long-term structural integrity after 
implantation, and has previously shown remarkable integration with the host tissue in different 
animal models.32-34,153 
 
5.5 In vivo evaluation of patient-specific BNC scaffold for auricular cartilage regeneration 
 
It is key in the field of auricular reconstructive surgery to control the external shape of the 
implant to obtain satisfying esthetic results. This outcome is often used as a measure of success 
for a potential scaffold.18,19,22 However, most efforts in auricular cartilage TE have used 
standardized auricular shapes.18,19,22,24 In this study, patient-specific auricular BNC scaffolds, 
with a bilayer architecture that integrates mechanical stability and high porosity, were 
successfully fabricated by combining the methods developed in Papers I-III (Figure 24). We 
believe that the optimal esthetic outcome would come from an implant that mimics the shape of 
the patient’s own auricle. The auricular BNC scaffold presented in this study was obtained from 
MRI data, which produces a result compatible with the patient’s expectation  (Figure 24a, g). An 
advantage of using MRI over X-ray computed tomography is the better soft tissue contrast 
provided by the former and hence, the direct visualization of articular cartilage.172 This makes it 
possible to produce patient-specific scaffolds that mimic the shape of auricular cartilage, rather 
than the whole outer ear (Figure 24g). 
 
 
Figure 24 – Fabrication of patient-specific auricular BNC scaffolds with a bilayer architecture composed of a dense 
BNC layer and a macroporous BNC-A composite layer. (a) First, a 3D model of human auricular cartilage was 
rapid prototyped (b) to make a negative auricular mold (c), which was then used to form and auricular dense BNC 
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layer. (d) The BNC-A porous layer was molded on top of the dense layer, followed by freeze-drying (e). (f) The 
ionic liquid EMIMAc was used to attach both layers to achieve a strong interfacial bonding. (g) After purification, 
patient-specific auricular BNC scaffolds with bilayer architecture were ready for implantation in a rabbit model. 
SEM images revealed an intact macroporous structure in the auricular BNC scaffolds after the 
fabrication process. The height of the porous layer was about 1.5 mm.  The dense BNC layer 
remained stable during the purification process, with an approximate height of 1 mm (Figure 25). 
 
 
Figure 25 – Scanning electron microscopy images showing the bilayer architecture of auricular BNC scaffolds. The 
dense BNC layer provides the mechanical stability, while the macroporous BNC-A composite layer supports cell 
ingrowth. 
In agreement with our previous results (Paper III), the dense and porous layers were stable and 
firmly attached, which facilitated the handling of the scaffolds during the purification process for 
8 weeks. The removal of endotoxins from the auricular BNC scaffolds was confirmed by 
bacterial endotoxin testing (Table 3). After 5 weeks of purification, the scaffolds had an 
endotoxin content of 0.526 ± 0.192 EU/ml, slightly above the endotoxin limit (0.5 EU/ml) for 
medical devices.90 Further washing with endotoxin-free water for 8 weeks yielded non-pyrogenic 
auricular BNC scaffolds (0.00658 ± 0.00214 EU/ml). The measured endotoxin content is in the 
same range as in the water used for purification (endotoxin specification <0.005 EU/ml) and 75 
times lower than the endotoxin limit set by the FDA. Furthermore, in vitro cytotoxicity testing 
revealed that the auricular BNC scaffolds were non-cytotoxic after 5 weeks of purification 
(Figure 26). The cell viability for the auricular BNC scaffold group (103.4 ± 7.7%) was 
significantly higher than the positive control group (31.2 ± 4.2%) at the p<0.05 level, and not 
significantly different to the negative control (100 ± 4.3%). This result confirmed the removal of 
EMIMAc residues from the auricular BNC scaffolds. Due to the large scaffold structures, the 
purification period of the auricular BNC scaffolds was much longer compared to the purification 
time of the bilayer BNC scaffolds presented in Paper III. Although the purification was lengthy, 
it was effective to yield non-pyrogenic and non-cytotoxic, patient-specific auricular BNC 
scaffolds ready for implantation in an immunocompetent rabbit model. 
 
Table 3 – Endotoxin analysis of auricular BNC scaffolds after 5 and 8 weeks of purification in endotoxin-free water 
(n=3 per time point). 
Weeks of purification Dilution Spike recovery (%) Endotoxin Units / ml 
5 1:10 137 ± 4 0.526 ± 0.192 
8 1:1 69 ± 4 0.00658 ± 0.00214 
 
a b 
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Figure 26 – In vitro cytotoxicity testing of auricular BNC scaffolds after 5 weeks of purification in endotoxin-free 
water (n=3). No significant differences were observed between the negative control and BNC scaffold groups, 
demonstrating the removal of cytotoxic ionic liquid residues from the auricular BNC scaffolds. Thus, the cytotoxic 
potential of such scaffolds was classified as non-cytotoxic. Error bars represent the standard deviation of the mean. 
*p<0.05 compared to negative control. 
 
 
Figure 27 – Photographs showing gross morphology of cell-free and rAC-seeded auricular BNC scaffolds pre-
implantation and after 6 weeks of subcutaneous implantation in immunocompetent autologous model. Auricular 
BNC scaffolds seeded with rabbit auricular chondrocytes. Scale bars indicate 1 cm. 
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Based on a qualitative assessment of shape and size of the implants, the cell-free auricular BNC 
scaffolds and the immunocompetent autologous tissue-engineered auricular grafts (i.e. rAC-
seeded auricular BNC scaffolds) maintained a good structural integrity after 6 weeks of 
subcutaneous implantation in the immunocompetent rabbit model (Figure 27). On the other 
hand, the longest in vivo study that has evaluated immunocompetent autologous tissue-
engineered auricular grafts with different polymeric scaffolds (PGA coated with PLA, PCL and 
P4HB) reported a severe foreign body reaction in all investigated scaffolds and a severe 
deformation and collapse of the implants at 3 months post-implantation.22 Most scaffold materials 
evaluated for auricular cartilage TE have been synthetic biodegradable polymers.16,22,65-67 
20,21,23,68,69
 Thus, many studies have resulted in poor shape and size stability of the auricular 
scaffold after implantation due to the short-lived chemical and mechanical stability of the 
scaffold materials. In agreement with our results, recent studies that have evaluated non-
degradable biomaterials in immunocompromised mice models have also reported a better 
structural integrity of the implant.18,19,24 Although in this study the auricular BNC scaffolds were 
not evaluated for longer implantation times, we speculate that the implants would still retain their 
3D structure since BNC is a non-degradable biomaterial with good chemical and mechanical 
stability. In a clinical context, the long-term structural integrity of auricular BNC scaffolds should 
not be compromised after implantation since humans do not produce enzymes capable of 
breaking down cellulose.70 This would allow the BNC implants to retain the shape of the auricle 
after implantation. 
 
 
Figure 28 – Histological and immunohistochemical evaluation of ECM in auricular BNC scaffolds seeded with 
rabbit auricular chondrocytes. (a) RAC-seeded auricular BNC scaffolds after 2 weeks of in vitro culture, (b) 
followed by 6 weeks of subcutaneous implantation. (c) Cell-free auricular BNC scaffolds at 6 weeks post-
implantation. Samples were stained with Alcian blue and Verhoeff’s stain to detect deposition of sulfated 
glycosaminoglycans and elastic fibers, respectively. Immunohistochemical staining was used to detect aggrecan and 
type II collagen. 
Alcian blue Aggrecan Collagen II Verhoeff's stain  
a 
b 
c 
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Besides maintaining a good structural integrity, the tissue-engineered auricular graft provided a 
scaffold architecture that is mechanically stable and porous to support cell ingrowth and 
neocartilage formation. As demonstrated in Figure 28a, the porous layer supported the ingrowth 
and homogenous distribution of rACs.  A high cell density and positive stain for s-GAG were 
observed in the porous scaffold layer, especially at the top part, after 2 weeks of in vitro culture. 
Of particular interest is the arrangement of the chondrocytes in the porous layer, which were 
contained in cavities that resemble cartilage lacunae. Although the isotype control showed a non-
specific background signal in the dense BNC layer caused by the anti-aggrecan antibody, areas 
around the lacunae were also stained positive for aggrecan after 2 weeks of in vitro culture. As 
expected, a stronger positive immunostain for aggrecan and staining for s-GAG were observed 
around the lacunae at 6 weeks post-implantation (Figure 28b). The same observation was made 
for type II collagen as in aggrecan. A non-specific immuno stain for collagen II was detected in 
the BNC. However, this important structural protein was also synthesized by the rACs in the 
auricular BNC scaffolds, as demonstrated by the positive immunostaining of type II collagen 
around the lacunae. A slight positive staining for elastic fibers was found in the lacunae within 
the porous layer at 6 weeks post-implantation, as shown by the Verhoeff's stain. The cell nuclei 
were stained black, whereas the fibrous-like structures inside the lacunae and around the cells 
were stained with a dark blue color (Figure 28b). The cell-free auricular BNC scaffolds 
supported the ingrowth of the surrounding cells from the host tissue. The surrounding cells 
infiltrated the porous layer completely or in some cases the ingrowth was mostly at the surface. 
As expected, ECM was synthesized by these cells and no cartilage cartilage-specific matrix was 
detected at 6 weeks post-implantation (Figure 28c). 
 
 
Figure 29 – Biomechanical evaluation. (a) Instantaneous and (b) equilibrium moduli of cell-free and rAC-seeded 
auricular BNC scaffolds at 6 weeks post-implantation (n = 18 per group). Error bars represent the standard 
deviation of the mean. 
Biomechanical evaluation was performed on cell-free and rAC-seeded auricular BNC scaffolds 
after 6 weeks of subcutaneous implantation. A typical stress relaxation behavior was observed in 
both groups (cell-seeded and cell-free controls). The following measurements were determined 
for the rAC-seeded auricular BNC scaffolds at 6 weeks post-implantation: 986 ± 365 kPa for Ein 
and 343 ± 156 kPa for Eeq (Figure 29). A Wilcoxon–Mann–Whitney test indicated a significantly 
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higher (p < 0.05) Ein in the rAC-seeded group compared to the cell-free group (768 ± 391 kPa) 
at 6 weeks post-implantation. Furthermore, no significant differences in Eeq were detected 
between the cell-free (317 ± 186 kPa) and rAC-seeded groups. The significant increase of Ein in 
the rAC-seeded auricular BNC scaffolds implies an improved capacity of the tissue-engineered 
graft to retain water, which is likely due to the neo-synthesis of s-GAG and aggrecan. Ein 
describes the instantaneous incompressible behavior of the tissue-engineered construct. 
 
In this study, we demonstrate a scaffold material and architecture as well as a biofabrication 
method of patient-specific tissue-engineered auricles with potential for auricular reconstruction. 
Patient-specific auricular BNC scaffolds, composed of a dense BNC layer and a macroporous 
BNC-A composite layer, were designed based on the mechanical requirements of human 
auricular cartilage and the porosity requirements for tissue growth. After 6 weeks of 
subcutaneous implantation in an immunocompetent rabbit model, we demonstrated that the 
auricular BNC scaffolds maintained a good structural integrity throughout the in vivo study and 
the porous layer supported the ingrowth of rACs and neocartilage formation. On the basis of 
these results, we propose BNC as a promising non-degradable scaffold biomaterial for auricular 
cartilage TE. 
 
5.6 3D bioprinting of human chondrocyte-laden nanocellulose hydrogel for patient-specific 
auricular cartilage regeneration 
 
In Paper IV 3D chondrocyte-laden auricular constructs with an open inner structure and high 
shape fidelity were successfully bioprinted with a novel bioink, composed of cellulose nanofibrils 
and alginate, and evaluated in long-term 3D culture for auricular cartilage TE. A crucial and 
important prerequisite for successful bioprinting is the innocuousness and cytocompatibility of 
the bioprinting process and the cell-carrier hydrogel, the bioink. The results from the indirect 
cytotoxicity test demonstrate that no cytotoxic effects were caused by the NFC-A bioink, 
bioprinting process and crosslinking solution on the indicator cells, hNCs and rACs (Figure 30). 
There were no significant differences in cell viability between the NFC-A and negative control 
groups. Furthermore, the viability for hNCs and rACs cultured with undiluted NFC-A extracts 
under standard (96.0 ± 6.2% and 99.2 ± 2.3%, respectively) and sensitizing (94.5 ± 5.9% and 
93.6 ± 6.5%, respectively) culture conditions was not significantly different; verifying the non-
cytotoxicity of the NFC-A bioink. These results are in good agreement with previous studies that 
have tested the cytocompatibility of NFC with human dermal fibroblasts173 and hepatic 
progenitor HepaRG cells.174 
 
Another prerequisite for bioprinting is to be able to operate in an aqueous environment, which 
restricts the choice of materials.101,103 In this study, cell-laden NFC-A auricular constructs with 
high shape fidelity were successfully bioprinted due to the highly viscous, shear-thinning bioink 
(Figure 31a and b). It is well know that NFC exhibits a high zero-shear viscosity and shear-
thinning behavior, even at low solid content. Moreover, the high viscosity is established 
instantaneously after shearing has stopped.124,174 All these important rheological properties 
combined with the rapid crosslinking property of alginate are required for easy dispensing of the  
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Figure 30 – In vitro cytotoxicity test of NFC-A bioink. Human nasal chondrocytes (hNC) and rabbit auricular 
chondrocytes (rAC) were used as indicator cells to determine cytotoxic effects potentially caused by bioink 
components, crosslinking or bioprinting process. 10% Dimethyl sulfoxide (DMSO) was used as positive control. 
HNCs and rACs cultured in the NFC-A bioink extracts demonstrate a high viability and reflect the non-cytotoxicity 
of NFC-A bioink. Error bars show 95.0% CI of mean. (*p < 0.05). (Paper IV) 
 
Figure 31 – (a) 3D bioprinting process of chondrocyte-laden NFC-A auricular constructs with open porosity. 
Blueprint shows the toolpaths of the support (PCL, white) and object (NFC-A, green) materials. (b) 3D bioprinted 
auricular and (c) lattice-structured constructs, laden with hNCs, after 28 days of culture. Scale bars indicate 1 mm. 
(Paper IV) 
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hydrogel at low pressures (< 40 kPa); maintaining a high shape fidelity during and after 
bioprinting; and keeping the cells in a 3D environment after crosslinking the cell-laden bioink 
constructs. Until now, hydrogels based on natural polymers have been regarded as having a sub-
optimal printability compared to synthetic hydrogels such as pluronics.175 A bioink with a high 
zero-shear viscosity and a fast response to re-establish the high viscosity after extrusion is 
required to avoid sedimentation of the cells and to keep a high shape fidelity during the 
bioprinting process. These two rheological properties are illustrated by the end results of the 3D 
cell-laden NFC-A auricular constructs presented in this study (Figure 31a and b). Furthermore, 
the cell-laden NFC-A constructs showed an excellent shape and size stability after bioprinting 
and 3D culture for up to 28 days, demonstrating the stability of the NFC-A network after 
crosslinking (Figure 31b and c). 
 
 
Figure 32 – Live/Dead cell imaging analysis. a) Percent viability of human nasoseptal chondrocytes (hNC) before 
and after embedding in NFC-A bioink and after bioprinting process. Error bars show 95.0% CI of mean. (*p < 
0.05). Representative images showing live (green) and dead (red) hNCs (b) after embedding and crosslinking; (c) 
after 3D bioprinting and crosslinking of cell-laden NFC-A constructs; and (d) in 3D bioprinted constructs 
throughout 28 days of 3D culture. Scale bars indicate (b, c) 100 µm and (d) 200 µm. (Paper IV) 
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To assess the influence of embedding, bioprinting and crosslinking processes on cell viability, 
we performed a Live/Dead staining based on a cell-permeable dye for staining of live cells and a 
cell-impermeable dye for detection of dead cells. We examined the cell viability before 
embedding the hNCs in NFC-A bioink; after embedding and crosslinking; and after embedding, 
bioprinting and crosslinking the cell-laden NFC-A constructs (Figure 32a). A Kruskal–Wallis 
ANOVA on ranks was conducted to compare the effect of embedding and bioprinting on cell 
viability. There was a significant effect of the handling of the cells on levels of cell viability for 
the three tested conditions, H(2, 10) = 6.49, p < 0.05. Post hoc comparisons using the Dunn’s test 
indicated that the mean cell viability after embedding and crosslinking processes (68.5 ± 6.9%) 
was significantly lower than before embedding the hNCs (96.5 ± 2.1%) at the p < 0.05 level. 
Moreover, there was no significant difference between the after embedding and after bioprinting 
(70.9 ± 7.2%) conditions, indicating that the bioprinting process had no significant influence on 
cell vitality (Figure 32a-c).  
 
A homogeneous cell distribution was observed after embedding the hNCs in NFC-A bioink and 
bioprinting the constructs, indicating a successful mixing process and capability of this bioink to 
keep the cells in suspension due to its high zero-shear viscosity (Figure 32b-d). Furthermore, we 
examined the viability of hNCs in the NFC-A constructs qualitatively, throughout the 28 days of 
culture, using live/dead cell imaging analysis. Directly after embedding, a loss of chondrocytes 
was detected, but these were able to recover during 3D culture. Less dead hNCs were present in 
the bioprinted constructs after day 7 compared to day 1, indicating a higher cell viability and cell 
recovery post-bioprinting. Moreover, cell recovery improved as the 3D culture progressed, as 
indicated by the decrease of dead cells embedded in the bioink. Also, an increase in cell numbers 
could be observed after 28 days of culture (Figure 32d). 
 
The qualitative results from cell imaging, pointing towards cell proliferation in the NFC-A 
hydrogels, were confirmed by biochemical analysis. A Wilcoxon–Mann–Whitney test indicated a 
significantly higher (p < 0.05) cell number per construct after 28 days (5.65 × 105 ± 1.11 × 105), 
compared to 14 days (3.98 × 105 ± 1.05 × 105) of 3D culture (Figure 33a). Furthermore, hNCs 
demonstrated the capacity to synthesize GAGs in the NFC-A bioink after 14 and 28 days of 
culture in chondrogenic differentiation medium. A Wilcoxon–Mann–Whitney test showed a 
significant difference (p < 0.05) between mean GAG content per scaffold after 14 days (21.0 ± 
9.1 µg GAG) and 28 days (40.6 ± 11.8 µg GAG) of culture (data not shown). Although total 
GAG-production was 2-fold higher at day 28 compared to day 14, the synthesis rate of GAGs—
measured in chondroitin sulfate equivalents per cell—was not significantly different between day 
14 (54.6 ± 24.8 pg/cell) and day 28 (72.0 ± 22.0 pg/cell) (Figure 33b).  
 
Our results demonstrated the capacity of hNCs to build up neocartilage tissue, by synthesizing 
and accumulating sulfated GAGs in the NFC-A bioink during 3D culture in chondrogenic 
differentiation medium. We also investigated whether chondrocytes maintain their capacity for 
tissue remodeling and turnover. For this purpose, we analyzed the matrix regulatory agents 
MMP-2 and MMP-9 by gelatin zymography. The results revealed that the pro and active form of 
MMP-2 were abundantly expressed and secreted on day 14. After 28 days, the expression of pro-
MMP2 per cell decreased, while the secretion of active-MMP2 remained stable. Both forms of 
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MMP-9 were secreted on at much lower levels compared to MMP-2 and remained stable 
between day 14 and 28 (Figure 33c and d). Matrix metalloproteinases (MMPs) are a family of 
Zn2+-dependent endopeptidases, essential for the degradation and timely breakdown of ECM 
during development, morphogenesis, and tissue remodeling under pathological, as well as normal 
physiological conditions.176,177 It has been shown that both MMPs are expressed in moderate 
levels in hyaline cartilage and in vitro, where MMP-2 is expressed in higher levels than MMP-
9.178 Our results confirmed this finding and show that hNCs support tissue remodeling in NFC-A 
bioink.  
 
Figure 33 – Quantitative biochemical assays for characterization of hNC proliferation, GAG neo-synthesis and 
release of matrix metalloproteinases, MMP 2 and MMP9, during 3D culture for up to 28 days in NFC-A bioink. (a) 
Cell number per scaffold. HNCs proliferate in NFC-A bioink and a significant increase in cell number is observed 
after 28 days. (b) The GAG content per cell increases clearly from day 14 to day 28 in 3D culture. (c) Release of 
pro- and active-MMP2 and (d) pro- and active-MMP9 in 3D culture of hNC in NFC-A bioink. Error bars show 
95.0% CI of mean. n = 6 per time point, *p < 0.05. (Paper IV) 
The local environment provided to chondrocytes affects not only their morphological appearance 
but also their differentiation status.179-181 The redifferentiation and re-organization of the gene 
expression pattern of hNCs, shown by the up-regulation of the examined chondrogenic markers 
at the gene and protein levels (Figure 34), could be attributed in part to the highly hydrated, 
fibrous 3D environment provided by the NFC-A bioink. This biologically relevant aqueous 3D 
environment, composed of cellulose nanofibrils with morphological similarity to collagen, 
provides the hNCs with a milieu that resembles their natural matrix; while the excellent 
printability of this bioink make it possible to bioprint complex, anatomically-shaped cell-laden 
constructs with a controlled cell density. 
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Figure 34 – (a) Comparative expression of redifferentiation and dedifferentiation marker genes in human nasoseptal 
cartilage and hNCs after monolayer expansion (day 0) and after 3D bioprinting in NFC-A bioink and cultured for 14 
and 28 days. The data is presented as the fold change in gene expression normalized to GAPDH and relative to 
human nasoseptal cartilage (dashed line). Error bars show 95.0% CI of mean. (*p < 0.05). (b) Histological Alcian 
blue staining of sulfated glycosaminoglycans (s-GAG), and immunohistological staining specific for aggrecan, 
collagen type II, cartilage oligomeric protein (COMP) and matrilin-3 in hNC-laden NFC-A constructs after 14 and 
28 days of culture. Nuclei are counterstained with Hematoxylin. (Paper IV) 
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As a consequence of hNC amplification in monolayer culture, gene expression of all examined 
markers was down-regulated and detectable only at very low levels (Figure 34a). When cultured-
expanded hNCs were embedded and cultured in the NFC-A bioink the pattern of gene expression 
started to revert to a more differentiated state. During the first 14 days in 3D culture, the 
expression of the cartilage-specific markers ACAN (1.09 × 10-2 ± 5.32 × 10-3-fold), COMP (8.381 
± 4.72-fold), MATN3 (1.09 × 10-2 ± 7.12 × 10-3-fold) and SOX9 (3.75 × 10-2 ± 2.21 × 10-2-fold) 
was significantly (each p < 0.05) up-regulated compared to monolayer culture (day 0). The 
expression of COL2A1 (1.68 × 10-3 ± 1.41 × 10-3-fold) was also up-regulated, but not 
significantly. In addition, hNCs exhibited a significant (each p < 0.05) up-regulated expression of 
COL1A1 (9.98 × 10-1 ± 3.65 × 10-1-fold) and VCAN (1.20 ± 0.33-fold), both generally accepted as 
markers for chondrocyte dedifferentiation, as well as RUNX2 (8.24 × 10-2 ± 4.11 × 10-2-fold). 
Although the increase in gene expression was significant between day 0 and 28, no significant 
changes occurred between day 14 and 28 (Figure 34a) 
 
The results of gene expression were confirmed on protein level by histological and 
immunohistochemical stainings. The results shown in Figure 34b demonstrate a homogenous 
distribution of hNCs with round shape morphology in the NFC-A bioink during 3D culture. 
Furthermore, a homogeneous deposition of sulfated GAGs within the hNC-laden NFC-A 
constructs was clearly visualized together with large cell aggregates, where a strong positive stain 
for s-GAGs was detected around the clusters of hNCs after 28 days in 3D culture. A positive 
immunostain for aggrecan was also observed around single hNCs already after 14 days of culture, 
whereas an enhanced accumulation of aggrecan was observed in cell clusters after 28 days of 3D 
culture. Moreover, cells growing inside the pores of the gridded constructs were found along with 
neo-synthesized ECM components such as GAGs around the stretched hNCs. The out-growing 
cells built up a superficial layer on the bioink surface. These cells exhibited the capacity to 
produce GAGs, aggrecan and collagen type II. After 14 days of culture, a positive immunostain 
for collagen type II was observed mostly at the edges of the constructs and as the culture 
progressed larger areas positive for collagen II were found. 
 
In agreement with gene expression, de novo synthesis of COMP by hNCs was already observed 
after 14 days in 3D culture. COMP was found around single cells, cell clusters and further away 
from the cells, in the bioink matrix surrounding the embedded hNCs, after 28 days of culture. 
COMP belongs to the major non-collagenous proteins in cartilage and is tightly regulated during 
chondrocyte de- and re-differentiation.182 COMP expression is abruptly down-regulated during 
dedifferentiation in monolayer expansion and is re-expressed in chondrocytes cultivated in 
3D.182,183 Our results confirm the observations of earlier 3D studies with alginate beads.182 A 
significant increase of COMP was detected on gene expression and protein levels, already after 
14 days in 3D culture (Figure 34a and b). Down-regulation of COL2A1 and COMP during 
monolayer amplification has severe negative consequences on the assembly, integrity and 
stability of newly synthesized ECM.182 Therefore, the up-regulation of gene expression and 
increased deposition of COMP and collagen type II in hNCs after 3D culture in NFC-A bioink is 
an important finding, since it reveals the redifferentiation capacity of hNCs in NFC-A bioink 
(Figure 34a and b). 
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Our results show that the expression of MATN3 in hNCs increased significantly during 3D 
culture in NFC-A bioink. Accompanied by the enhanced gene expression, we detected 
depositions of matrilin 3 as pericellular filamentous networks surrounding the hNCs embedded in 
the NFC-A bioink after 14 and 28 days of 3D culture (Figure 34a and b). Matrilin 3 possesses 
regulatory function for the maintenance of cartilage ECM and prevention of premature 
chondrocyte hypertrophy,184 acts as modulator of collagen fibrillogenesis, and interacts with 
collagen type II and IX, proteoglycans and COMP.185,186 The expression and neosynthesis of 
GAGs, collagen type II, aggrecan, COMP and matrilin 3 by the hNCs, observed in the bioprinted 
cell-laden constructs during 3D culture, could be attributed in part to the biologically relevant 
aqueous 3D environment that the bioink provides to the cells—mimicking the morphology of 
their natural matrix while providing a more controlled and relevant cell density. According to 
Kaps et al., chondrocyte differentiation is initiated by 3D assembly, which subsequently results in 
the regulation of proliferation-associated genes and initiates re-differentiation.183 In this context, 
the up-regulation of all cartilage-specific markers (ACAN, COL2A1, COMP, MATN3 and SOX9) 
during 3D culture in NFC-A bioink suggests that the dedifferentiation of hNCs, following 
expansion in monolayer, is reversed by subsequent 3D assembly in an aqueous 3D environment 
that mimics the morphology of their natural matrix; whereat chondrogenic developmental 
sequences are re-initiated. 
 
5.7 Mechanical stimulation of cell-seeded BNC scaffolds to enhance neo-tissue development 
 
In Paper V80 a compression bioreactor was utilized to apply dynamic mechanical stimulation to 
cell-seeded constructs as a means to enhance production of extracellular matrix in vitro. The 
SEM images of BNC scaffolds clearly confirmed that the macro-channels remained open after 
removal of the cylindrical porogens, where the diameter of the macro-channels was 
approximately 600–700 µm (Figure 35). The open macro-channeled architecture of the BNC 
scaffolds facilitated the seeding of the cells and the transport of nutrients inside the channels. 
 
 
Figure 35 – SEM images of macro-channeled BNC scaffolds. (a) Cross-section and (b) top-view images of macro-
channel. (Paper V) 
As both cellulose and collagen are visualized with SHG microscopy, correct interpretation of 
SHG images requires differentiation between the materials. For this purpose, corresponding 
a b 
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SHG, CARS, and brightfield images from a macro-channel boundary region were compared. In 
brightfield images, it was generally easy to differentiate between the BNC and the macro-channel 
(µc)/cell regions (Figure 36). Although, individual cellulose fibers can be readily visualized with 
SHG microscopy,128 the dense cellulose network appears rather homogeneous in the 200 × 200 
µm2 field of view of the acquired SHG images  (Figure 36b, BNC). Furthermore, the cellulose 
gave a relatively constant background signal in the CARS image (Figure 36c, BNC).  In contrast, 
SHG and CARS visualize the µc/cell region differently. The compact matrix of the µc/cell region 
gives a non-uniform signal in the CARS image, consistent with the morphology of the region and 
here shown in orange-brown color (Figure 36c, µc/cell). Moreover, a strong signal and high 
CARS image contrast is obtained from lipid droplets visualized in bright yellow color. The SHG 
image of the macro-channel (µc)/cell region shows a developed fiber network identified as SHG-
active collagen because of its location and the dimensions of the fiber network, compared to the 
denser and homogenous cellulose shown in the lower right corner of the SHG image (Figure 
36b). In addition, the fibers in the µc/cell region show higher SHG intensity compared to the 
cellulose; in agreement with the strong SHG signals generally obtained from collagen type I.127 
This confirms that the SHG signal obtained in the µc/cell region originates from collagen (Figure 
36b). 
 
Figure 36 – Microscopy images of cell-seeded macro-channeled BNC scaffold after 14 days in static culture. (a) 
Brightfield image shows the overall cell arrangement in the macro-channel (µc)/cell region, where the boundary of 
the macro-channel is clearly identified. (b) Specific imaging of collagen fibers (blue color) in the indicated region of 
interest (inset in image a) is provided by SHG microscopy, which also visualizes the cellulose scaffold (BNC). (c) 
The fibroblasts can be probed by CARS microscopy, useful for confocal imaging of the cell matrix (µc/cell, orange–
brown color). (Paper V) 
Cells seeded on unmodified BNC scaffolds were able to align at local level, but were more 
randomly oriented at a larger scale after 14 days of culture (Figure 37a). The macro-channels 
were highly populated by fibroblasts and the cells were aligned at the local- and large-scale in the 
constructs cultured under static conditions already at 14 days; demonstrating the role of the 
macro-channels to guide cell growth (Figure 37f-h). For individual fibroblasts, cell orientation is 
locally determined by neighboring cells. As the cells proliferate and reach the boundaries of the 
macro-channels, it results in cell layers oriented parallel to the direction of the channels. SHG 
microscopy images revealed that this cell alignment also resulted in the synthesis of collagen 
fibers aligned along the channel. Comparison between SHG and brightfield images shows an 
alignment of collagen fibers and cells along the channel direction for construct cultured in static 
as well as dynamic conditions (Figure 37f-j, arrows).  
 
BNC 
µc/cell µc/cell 
BNC BNC 
a b c 
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Figure 37 – SHG and brightfield microscopy images from cell-seeded (a–e) unmodified and (f–j) macro-channeled 
BNC scaffolds cultured in static (upper rows) and dynamic conditions (lower rows) at day 14, 21, and 28. The SHG 
images visualize collagen fibers and the brightfield images show cell pattern at a larger scale. Macro-channeled 
scaffolds show an alignment of cell pattern and collagen fibers along the channel (f–j). Samples from the dynamic 
culture show higher amount of collagen fiber networks compared to the static culture. Insets indicate regions of SHG 
images and the arrows indicate macro-channel directions. Scale bar size 20 µm. (Paper V) 
Cells seeded in macro-channeled BNC scaffolds and cultured in static conditions showed 
collagen fiber networks after 14 days of culture (Figure 37f). However, weaker SHG signals 
were observed in samples collected at day 21 and 28 (Figure 37b, c, g, h). SHG signals positive 
for collagen were expected in samples from the static culture, as collagen secretion is a primary 
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task of fibroblasts. Thus, the static culture served as a base-line control for the dynamic culture. 
In contrast to the static culture, SHG images of constructs from the dynamic cultures showed 
stronger SHG signal and demonstrated collagen fiber networks (Figure 37d, e, i, j, see intensity 
scales). SHG microscopy has been used extensively for visualization of fibrillar collagen 
structures.187-190 On the basis of the amount of fibers and the signal strength in SHG images from 
the dynamic cultures, it is clear that the collagen production was enhanced by the mechanical 
stimulation (Figure 37 and Figure 38). Figure 38 shows three-dimensional arrangements of 
collagen fibers and cells in volume views rendered from stacks of SHG and CARS images 
measured on constructs during dynamic culture (days 21 and 28). In the overlay volume views 
(left), showing collagen fibers (blue) and cell layers (orange), it can be observed that the collagen 
fibers are embedded in the cell matrix and appear anchored to the cells (Figure 38, arrows). 
Furthermore, fiber alignment is maintained through multiple layers of cells in the macro-
channeled BNC scaffolds, as shown by the box views (right) of the collagen fiber networks 
(Figure 38c, d).  
 
 
Figure 38 – SHG and CARS microscopy volume views of collagen fibers (blue) and fibroblasts (brown–orange) in 
(a, b) unmodified and (c, d) macro-channeled BNC scaffolds cultured under dynamic conditions at day 21 (a, c) and 
28 (b, d). Overlay SHG and CARS volume views (left) show that fibers are embedded in the cell matrix (a, arrows). 
Separate visualization of the collagen fiber networks (box views, right) shows the multilayer arrangement of fibers. 
Note the alignment for the macro-channeled scaffolds (c, d). Lateral image dimensions 200 × 200 µm2, vertical 
image dimensions 30 µm (a, b, d) and 50 µm (c). (Paper V) 
Our findings show that the macro-channels facilitate the alignment of the cells along the 
channels, which results in the secretion of collagen fibers oriented in the same direction. 
Furthermore, collagen production is enhanced by dynamic mechanical stimulation under 
physiologically relevant loading conditions. The use of bioreactors is essential for the 
development of tissue-engineered cartilage in vitro, where mechanical stimulation can be easily 
applied to cell-seeded BNC scaffolds to aid in the development of the neo-tissue. Cell migration, 
ECM deposition, and complex tissue differentiation, among other forms of cell behavior, are 
regulated by mechanical stimuli. Mechanosensitive tissues, such as bone and cartilage, are known 
A B 
C D 
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to adapt their developmental programs in response to applied mechanical stresses. This smart 
feature allows our tissues to specifically adapt to their working conditions.191,192 Thus, it is of 
extreme importance to develop tissue-engineered constructs under a physiologically relevant 
mechanical environment 
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CHAPTER 6 
 
6 CONCLUDING REMARKS 
In Paper I we aimed to assess whether BNC is a mechanically appropriate implant material for 
auricular cartilage replacement. For the first time, mechanical properties of human auricular 
cartilage were determined in order to define a benchmark required for BNC and other scaffold 
materials aimed at auricular cartilage TE. Although tissue samples from only 4 donors were 
tested, this benchmark was considered more appropriate than using published mechanical 
properties of hyaline cartilage or fibrocartilage. The compressive mechanical properties of BNC 
materials could be tuned (Eeq: 0.06 to 3.2 MPa) to match the mechanical requirements of human 
auricular cartilage (Eeq: 3.3±1.3 MPa) by increasing the cellulose content to 14%. Additionally, 
we demonstrated a novel biofabrication process to produce patient-specific BNC implants with 
complex 3D shapes such as a human auricle. Based on these results, it was concluded that BNC 
shows promise for engineering non-degradable auricular implants with tunable, patient-specific 
mechanical properties and shapes. Based on the mechanical requirements of auricular cartilage 
and the porosity requirements for tissue growth, this study led to the design of a BNC scaffold 
with a bilayer architecture that combines mechanical stability (i.e. dense BNC layer) and high 
porosity (i.e. macroporous BNC-A composite layer). 
 
In Paper II, we investigated the host tissue response to densified BNC hydrogel with cellulose 
content of 17 %, since this material was considered a mechanically appropriate scaffold material 
for auricular cartilage TE (Paper I). It was considered of utmost importance to first evaluate the 
purity, pyrogenicity and cytotoxicity of the densified BNC hydrogel, before an in vivo 
biocompatibility study was conducted. Thus, a purification and depyrogenation process was 
developed and validated. As shown by the results from ESCA and bacterial endotoxin analysis, 
the first depyrogenation process extensively removed bacteria and its residues, particularly 
endotoxins, from the large BNC structures. The second depyrogenation process, consisting of 
rinsing with endotoxin-free water, was shown to reduce the endotoxin content in the densified 
BNC hydrogels down to 0.10 EU/ ml; well below the endotoxin limit for medical devices. 
Furthermore, biocompatibility testing according to standards set forth in ISO 10993 demonstrated 
that the purified and densified BNC hydrogel is non-cytotoxic and causes minimal foreign body 
response. Based on the recommendations of ISO 10993-6 Appendix E, autologous auricular 
cartilage and densified BNC implant groups were considered a slight irritant to the host tissue in 
a rabbit model. In support with our previous findings, in Paper II we concluded that the tested 
densified BNC hydrogel is a promising non-degradable biomaterial for auricular cartilage TE, 
due to its similarity with auricular cartilage in terms of mechanical strength (Paper I) and host 
tissue response. 
 
Since native and densified BNC hydrogels are impenetrable to cells, due to the lack of 
macroporosity, different methods were investigated to create porous BNC scaffolds that support 
cell ingrowth. A freeze-drying process was used to fabricate macroporous scaffolds composed of 
BNC and alginate, where the latter served as the binder of the scaffold matrix. The 
redifferentiation capacity of hNCs was studied in macroporous BNC-A composite scaffolds in 
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vitro, where the effect of scaffold composition on neocartilage formation was evaluated. Two 
groups of BNC-A composite scaffolds, 50/50 and 90/10, with similar macro-architecture but 
different pore surface topographies were investigated. Our results demonstrate that both 
composite scaffolds possess morphological properties appropriate for cell ingrowth, proliferation 
and neocartilage formation. After 42 days of 3D culture, depositions of cartilage-specific ECM 
such as GAGs, aggrecan and collagen type II were found notably in both BNC-A composite 
scaffolds. Although there was a higher expression of the evaluated chondrogenic markers in the 
50/50 BNC-A scaffold type, we selected the 90/10 BNC-A composite scaffold for further studies 
since it can be sterilized using an effective and reliable method, such as steam sterilization, 
without damaging the macroporous structure. 
 
In Paper III a novel BNC scaffold designed with a bilayer architecture that integrates 
mechanical stability and high porosity was successfully fabricated and evaluated for auricular 
cartilage TE, in vitro and in vivo. To achieve a strong interfacial molecular bonding between the 
scaffold layers, we used a novel cellulose solvent system consisting of the ionic liquid EMIMAc. 
This study demonstrates that non-pyrogenic and non-cytotoxic bilayer BNC scaffolds can be 
successfully produced. Furthermore, such scaffolds together with alginate provide a suitable 
environment for culture-expanded hNCs as well as freshly isolated hNCs and MNCs to form 
cartilage in vitro and in vivo. Most studies that have used biodegradable materials to engineer 
auricular cartilage have resulted in poor structural integrity of the scaffold after implantation due 
to the short-lived chemical stability of the scaffold material. This study found that bilayer BNC 
scaffolds offer a good mechanical stability and maintain a structural integrity while providing a 
porous architecture that supports cell ingrowth and neocartilage formation, as demonstrated by 
gene expression, immunohistochemical, biochemical and biomechanical analyses. This work, 
together with previous studies (Papers I and II), lead to the development of bilayer BNC 
scaffolds in the shape of a human auricle, with the aim to provide an effective treatment to 
serious auricular defects. 
 
Patient-specific auricular BNC scaffolds, composed of a dense BNC layer and a macroporous 
BNC-A composite layer, were designed and produced based on the mechanical requirements of 
human auricular cartilage and the porosity requirements for tissue growth. These scaffolds were 
fabricated by combining the methods developed in previous studies (Papers I–III), and evaluated 
in an immunocompetent rabbit model for six weeks. In this study, we demonstrated the capacity 
of rabbit auricular chondrocytes to synthesize cartilage-specific ECM components in the 
immunocompetent autologous grafts. Additionally the auricular shape of the BNC scaffolds was 
maintained throughout the in vivo study. We demonstrate a scaffold material and architecture as 
well as a biofabrication method of patient-specific tissue-engineered auricles with potential for 
auricular reconstruction. 
 
A bioprinting method of patient-specific auricular BNC scaffolds was first described in Paper I. 
However, the biofabrication of porous, auricular BNC scaffolds was not successful with this 
method. In Paper IV patient-specific, chondrocyte-laden auricular constructs with an open inner 
structure and high shape fidelity were successfully bioprinted using a novel bioink composed of 
cellulose nanofibrils and alginate, and evaluated for auricular cartilage TE. This study 
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demonstrates that NFC-A bioink is non-cytotoxic. Furthermore, the cell-laden NFC-A 
constructs showed increased cell viability and proliferation as well as an excellent shape and size 
stability throughout 3D culture for 28 days. Moreover, hNCs embedded in the bioink 
redifferentiated and underwent chondrogenesis, which resulted in neo-synthesis and 
accumulation of cartilage-specific extracellular matrix around the cells—as demonstrated by gene 
expression, immunohistochemical and biochemical analyses. Based on these results we can 
conclude that NFC-A bioink provides a biologically relevant environment that supports 
redifferentiation of human chondrocytes in vitro, while offering excellent printability—making it 
a promising bioink for auricular cartilage TE. 
 
The use of bioreactors is essential for the development of tissue-engineered cartilage in vitro. In 
Paper V a compression bioreactor was utilized to apply dynamic mechanical stimulation to cell-
seeded constructs as a means to enhance production of extracellular matrix in vitro. The three-
dimensional distributions of collagen fibers and fibroblasts in the cellulose scaffolds were studied 
under native, soft-matter conditions by combined second harmonic generation and coherent anti-
Stokes Raman scattering microscopy. The results revealed that macro-channels incorporated in 
BNC scaffolds facilitate the alignment of fibroblasts and, thus, the neo-synthesized collagen 
fibers. Furthermore, collagen production is enhanced by dynamic mechanical stimulation under 
physiologically relevant loading conditions for native cartilage. These two factors have made it 
possible to engineer a composite biomaterial consisting of oriented collagen fibers embedded in a 
cellulose matrix. 
 
In this thesis, we evaluated nanocellulose-based scaffold materials, purification methods, scaffold 
architectures and biofabrication methods of patient-specific tissue-engineered auricles with 
potential for auricular reconstruction. Based on the evidence from multiple studies, we propose 
BNC as a promising non-degradable biomaterial for auricular cartilage TE. Although the primary 
focus of this thesis has been on auricular reconstruction, the methods developed are also 
applicable in the regeneration of other cartilage tissues such as those found in the nose, trachea, 
spine and articular joints. 
 
 
6.1 SUGGESTIONS FOR FUTURE RESEARCH 
 
The compressive mechanical properties of BNC materials can be tuned to match the mechanical 
requirements of human auricular cartilage. However, the relaxation kinetics of the material need 
to be further improved. In future work it would be appropriate to introduce negative-charged 
groups in the BNC network to better mimic the relaxation behavior of native cartilage. It was 
expected that the GAGs produced by the seeded chondrocytes would be enough to improve the 
relaxation kinetics (higher t1/2 and τ) of the tissue-engineered constructs. However, this was only 
observed in the in vivo studies. The presence of charged GAGs in BNC can be mimicked by 
chemical modifications such as sulfonation or phosphorylation of the material, as demonstrated 
by Svensson et al.81 The importance of having negative-charged groups is not only to bind water, 
and hence improve relaxation kinetics, but also to bind the growth factors in the culture medium 
or those produced by the cells. 
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Macroscopic examination of the bilayer BNC scaffolds revealed a stable adhesion between the 
dense and porous layers, with no signs of adhesive failure after the in vitro and in vivo studies 
(Paper III). However, we also observed that when pulling the dense and porous layers apart the 
scaffold breaks at the porous layer, similar to a structural failure. We speculate that the interfacial 
bonding between the layers is stronger than the structure of the porous layer, since the 
mechanical stability of the BNC-A layer is dependent on the crosslinked alginate in the 
composite matrix. Thus, to improve the mechanical stability of the bilayer scaffold, the 
macroporous BNC-A layer would need to be replaced with a macroporous layer made of BNC 
only. Such macroporous BNC scaffolds can be produced during the biosynthesis of BNC using 
the techniques developed by Bäckdahl et al.149 or by post-processing techniques using laser 
ablation.75 The biofabrication of macroporous BNC scaffolds during the biosynthesis process is 
preferred, since it would yield macroporous scaffolds with a continuous network of cellulose 
nanofibrils. When combined with a dense BNC layer, it would most likely result in bilayer BNC 
scaffolds with better mechanical stability and interfacial strength. 
 
As cartilage is a mechanosensitive tissue, it would be necessary to culture tissue-engineered 
auricular constructs under a physiologically relevant mechanical environment, if these are to be 
matured in vitro before implantation. Thus, the physiological loading conditions for auricular 
cartilage must first be assessed to design an appropriate bioreactor for mechanical stimulation. 
Static and dynamic mechanical stimulation applied to chondrocyte-laden scaffolds would 
enhance cell proliferation and neocartilage formation, and thus, improve the neo-tissue’s 
mechanical properties. Also, elastic fibers play a major role in the mechanical properties of 
auricular cartilage. This underlines the importance of elastin synthesis in auricular cartilage TE 
attempts. Since auricular chondrocytes are necessary to produce elastic fibers, it would be 
appropriate to use a combination of auricular and nasoseptal chondrocytes to incorporate elastic 
fibers in the neocartilage.  
 
3D bioprinting offers endless possibilities to the future of tissue and organ regeneration. Using 
this technology it is possible to biofabricate chondrocyte-laden auricular constructs surrounded 
by a perichondrium-like layer, and covered by a layer with keratinocytes; mimicking more 
closely the native tissue architecture. 
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